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utilizing an equi-hypocaloric diet during a behavioral weight loss intervention 
By 
Michelle G. Kulovitz 
 
B.S., Exercise Biology, University of California, Davis, 2008 
M.S., Exercise  Science, University of New Mexico, 2010 
M.S., Nutrition, University of New Mexico, 2012 
Ph.D., Physical Education, Sports and Exercise Sciences,  
University of New Mexico, 2013 
 
ABSTRACT 
Background: Obesity prevalence is a global pandemic and a public health concern. 
Beneficial weight loss strategies are needed for obesity management. Increased daily 
meal frequency (MF) is often associated with improvements in blood-markers of health 
and appetite control during weight loss; however, this has not been confirmed using 
portion-controlled meal products to reduce underreporting error.  
Objective: The purpose of this study was to determine if increased MF can be a 
beneficial treatment strategy for weight loss in obese women by determining the changes 
of total ghrelin, blood glucose, insulin, lipid concentrations, and sensations of hunger and 
satiety due to an equi-hypocaloric diet intervention during a two meals per day sequence 
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(2 MF) versus a three meals and three snacks per day sequence (6 MF) using portion-
controlled products. 
Design: Eleven (N = 11) obese female subjects (BMI 39.1 ± 7.6 kg/m2) ages 52 ± 7 years 
completed a six-week study using a randomized cross-over design. Subjects were 
randomized to either the 2 MF or 6 MF treatment condition for two-weeks, had a two-
week washout of three meals and one snack per day, and then alternated treatment 
conditions. 
Results: All subjects lost a similar percentage of body weight 6.6 ± 1.6% (6.2 ± 1.9 kg) 
which was not significantly different (P > 0.05) between the 2 MF and 6 MF conditions. 
Percent change analysis in fat-free mass (FFM) showed significant differences between 
conditions. Results showed 3.3 ± 2.6% decrease in FFM following the 2 MF condition, 
while following the 6 MF condition there was an average increase of 1.2 ± 1.7% in FFM 
(P ≤ 0.05). There were no significant differences between conditions for fasting and  
area-under-the-curve (AUC) values of glucose, insulin, and total-ghrelin. Fasting high-
density lipoprotein cholesterol (HDL-C) concentrations were significantly lower than 
baseline during the 6 MF condition (49 ± 10 vs. 53 ± 12 mg/dL, respectively) where the 
percent change in HDL-C during the 2 MF condition was significantly higher than in the 
6 MF condition (1.3 ± 12.2% vs. 0.12 ± 10.3%). There was a significant decrease (P = 
0.006) in glucose AUC from baseline to the six-week follow up. There were no 
significant differences found for fasting triglycerides, total cholesterol, or low-density 
lipoprotein cholesterol (LDL-C) between conditions. There was a significant difference 
from baseline to the six-week follow-up respectively for glucose AUC (13,122  ± 1,726 
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vs 12,296 ± 1,870 mg/dL·120 min) and hunger ratings (1,894 ± 887 vs 3,131 ± 1,563 
mm·120 min, P < 0.05).  
Conclusions For our sample increasing MF from two to six occasions per day did not 
promote greater improvements in blood-markers of health, appetite control, or total-
ghrelin levels during a portion-controlled strict reduced-calorie diet intervention. 
Additionally, reduced MF may attenuate losses in HDL-C levels while increased MF may 
reduce losses in FFM during weight loss.  
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CHAPTER I 
Introduction 
Obesity is a complex issue for clinical weight management professionals. 
Changing feeding behaviors by implementing increased dietary structure is becoming 
more commonly included in weight management strategies for patients undergoing 
supervised weight loss interventions. Some hypocaloric diets to induce body weight loss 
do result in unfavorable metabolic changes that can lead to increased ratings for hunger 
and cravings, increased circulating ghrelin, and suppressed postprandial ghrelin decline 
following meals (1).  
Weight Loss and Meal Frequency 
One fundamental principle that seems to be the most common component to 
current clinically supervised hypocaloric diets is the idea of structured daily meal 
frequency (MF). Most current dietary weight loss plans have substituted the classical 
eating pattern of three large meals per day to eating more frequently per day to spread out 
daily caloric intake (1, 2). Optimal MF has been hypothesized to have an effect on energy 
intake and thus body weight regulation due to its potential role in resting metabolic rate 
(RMR), hunger and satiety, and hormonal appetite regulation (1, 3). However, there 
appears to be no consistency within the literature in regard to MF and the optimal number 
of meals and/or snacks per day for weight management and obesity-related disease risk 
reduction.  Nevertheless, most, if not all weight-loss programs advocate five or more 
small meals per day, providing claims that increased meal frequency can reduce self-
reported scores of hunger and cravings, improve glucose and insulin control, and improve 
body composition (1, 2). Consuming an equi-hypocaloric diet of differing MF during 
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weight loss has been reported to have no statistically significant impact on the amount of 
weight lost (4-7). However, there has been evidence that increased meal frequency may 
improve metabolic markers of health, fuel utilization, appetite measures, as well as 
hunger and craving scores (1, 8-11). In the long-term increased MF may help with weight 
loss and weight maintenance. 
Impact of Meal Frequency 
Currently, limited research with obese (BMI ≥ 30 kg/m2) subjects demonstrates 
the effects MF has on metabolic blood markers of health including serum glucose and 
insulin responses, serum lipid concentrations, total cholesterol, hormone levels (i.e. 
serum total ghrelin), and blood pressure (12, 13). One of the earliest studies showing the 
impact of MF on blood markers of health was done by Fabry et al. in 1964 (14). Along 
with results showing an inverse relationship of MF to body weight, Fabry and colleagues 
reported metabolic results showing that individuals who were currently consuming three 
or less meals per day had an increased prevalence of hyperinsulinemia and glucose 
intolerance compared to those consuming five or more meals per day (14). Additionally, 
two early studies by Gwinup and colleagues executed some initial descriptive 
investigations to study the effects of MF on serum glucose and lipids (15, 16). These 
studies demonstrated that 14 days of an equi-caloric diet of ten snacks versus three meals 
per day led to decreases in serum lipid and glucose concentrations (15, 16). It is 
important to note that these studies investigated normal-weight healthy adults.  
Since these first investigations there have been limited studies investigating the 
beneficial responses of MF on serum lipid, glucose, and insulin concentrations using 
obese (7, 9, 10, 17) or normal weight adults (13, 18-20). Additionally, even fewer studies 
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have investigated the impact of MF on metabolic markers of health using obese subjects 
undergoing weight loss utilizing a hypocaloric diet (5, 7, 10). Surprisingly, most studies 
investigating metabolic markers of health relied on self-reported dietary intake (7, 9, 13, 
18) where very few provided portion-controlled meals and/or meal replacements to 
control for measurement and portion control error (10, 17, 19). It has been shown that 
obese individuals significantly underreport energy intake, and obesity was found to be a 
significant predictor of underreporting energy intake (21, 22). One issue that may cause 
differing results among studies is that varied research methodologies have been used and 
limited research exists using strict dietary and calorie-controlled methods. More studies 
utilizing portion-controlled meals and/or meal replacements are needed to control for 
extraneous errors that typically occur with free-living dietary measures especially with 
participants who are undergoing weight loss.  
According to a recent review of literature, the research-based evidence supporting 
the influence of MF on appetite regulation is inconclusive (12). It has been suggested that 
a “nibbling” or grazing pattern of eating (those who eat more frequently throughout the 
day) exerts various metabolic benefits (i.e increased resting metabolic rate (RMR) and/or 
food thermogenesis) when compared to those “gorging” (those eating two or less meals 
per day) (12). Research utilizing a metabolic or respiratory chamber to determine whole-
body calorimetry during an isocaloric diet of varying MF showed no significant 
differences in acute changes in energy expenditure or food thermogenesis (6, 23, 24). 
Although acute changes in energy expenditure or food thermogenesis has not 
been demonstrated during the short-term with varied MF, research investigating appetite 
and hunger responses shows promising results with increasing MF. Studies investigating 
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the effects of preprandial and postprandial hunger and satiety ratings report that 
hormones (i.e. total ghrelin) may play a direct role in daily caloric consumption (11, 20, 
25). Using the visual analogue scale (VAS) for hunger, satiety and cravings, it has been 
demonstrated that VAS hunger scores can decrease and VAS satiety scores can increase 
with increased meal frequency (11, 20, 25). The VAS has been validated in previous 
appetite research to be an accurate measure for determining hunger, satiety, and/or food 
cravings at specific time periods (26). 
Additionally, it has been proposed that gastric emptying may play a role in hunger 
and satiety ratings. Eating frequently can delay gastric emptying which will increase food 
exposure to the gut and produce necessary hormonal cascades (27). It is proposed that 
these hormonal responses will increase satiety and decrease hunger when the same 
caloric intake is spread across smaller more frequent meals (27). 
Limitations in the Literature 
Presently, there are few studies that have investigated differences in obese 
individuals undergoing weight loss while eating varied MF. Furthermore, the 
investigation of  “gorging” (two meals per day) versus “nibbling” (three meals + three 
snacks per day) has yet to be explored in this population utilizing portion-controlled meal 
products. The “gorging” pattern of meal intake has been thought to enhance adipogenesis 
or fat storage and increase body weight; the weight gain is thought to be mainly attributed 
to the large fluctuations in fat storage and mobilization that occurs during gorging 
followed by prolonged periods of fasting (1, 28, 29).  
The potent circulating orexogenic hormone ghrelin is the only known circulating 
hormone that increases hunger (30). Circulating ghrelin is known to stimulate 
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adipogenesis, increase hunger ratings, as well as display an endogenous secretory 
rhymicity that can be related closely to meal patterns (29). Diet-induced weight loss has 
been associated with a decrease in postprandial ghrelin suppression which could be the 
cause of the eventual regaining of weight lost (1). In examining current research 
comparing obese individuals and lean counterparts, obese subjects were found to have a 
negatively correlated relationship of ghrelin to body weight and percent body fat (r = -
0.50, r = -0.53, respectively) (31). Additionally, according to Solomon et al. 2008 (32), 
there is a larger preprandial surge in ghrelin response with larger less frequent meals (two 
meals per day) versus smaller more frequent meals (12 snacks per day). This surge is 
thought to play a large role in disrupting metabolic balance by decreasing fat utilization 
and increasing fat storage. Although adiposity has been positively correlated with total 
ghrelin levels, the changes in total ghrelin in response to meal frequency during an equi-
hypocaloric diet is not fully understood.  
Problem Statement 
Studies investigating the effect of varied MF on hunger/satiety, biochemical 
markers of appetite, and blood markers of health have shown conflicting results in obese 
subjects. Comparing these parameters using two meals per day versus three meals + three 
snacks per day has yet to be investigated in obese subjects through a cross-over design 
and portion-controlled meals. Thus, the current aim of this doctoral dissertation project is 
to assess the changes in appetite, blood lipid profiles, glucose and insulin metabolism, 
and sensations of hunger and satiety in obese women utilizing a commercially available 
weight loss program of varying meal frequencies as part of their clinically-supervised 
behavioral weight management program.  
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Purpose of Study 
The purpose of the present study is to determine the effects of an equi-hypocaloric 
diet with varying meal frequency of “gorging” (two meals per day) versus “nibbling 
(three meals + three snacks per day) on total ghrelin, blood glucose, insulin, and lipid 
concentrations, and sensations of hunger and satiety during a six-week cross-over design.  
Hypotheses  
This study will test the following hypotheses: 
1. There will be a significant difference (P ≤ 0.05) in metabolic markers of health 
when subjects consume the two meals/day “gorging” sequence versus the three 
meal + three snacks/day “nibbling” sequence.  
a. It is hypothesized that fasting total cholesterol will decrease in response to 
the “nibbling” sequence following a test meal.  
b. It is hypothesized that fasting LDL cholesterol will decrease in response to 
the “nibbling” sequence following a test meal.  
c. It is hypothesized that fasting insulin AUC concentrations will decrease in 
response to the “nibbling” sequence following a test meal.  
d. It is hypothesized that fasting glucose AUC concentrations will decrease 
in response to the “nibbling” sequence following a test meal.  
Rationale: According to recent literature, LDL-C and total cholesterol as well as 
decreased fasting insulin and blood glucose responses all decrease with increased 
meal frequency (10, 13, 20). Additionally, early studies using healthy normal-
weight subjects also reported that those who habitually consume two or less meals 
per day have an increased prevalence of hyperinsulinemia and glucose intolerance 
	  	  
7	  
compared to subjects consuming five or more meals per day (14); however, this 
has yet to be confirmed in obese subjects. 
2. There will be a significant difference in VAS hunger and satiety ratings following 
the test meal for the allocated time intervals of 0, 30, 60, 90, and 120 minutes 
between the two test conditions. 
a. It is hypothesized that VAS hunger ratings AUC following a test meal will 
be significantly decreased following the two-week trial consuming the 
“nibbling” pattern versus “gorging” pattern. 
b. It is hypothesized that VAS satiety ratings AUC will be increased 
following the two-week trial consuming the “nibbling” pattern versus 
“gorging” pattern. 
Rationale: Bachman and Raynor (3) and Smeets et al. (11) reported that 
individuals with a higher frequency eating pattern of an isoenergetic diet gave 
lower hunger and increased satiety ratings as compared to those having a less 
frequent eating pattern. The increased MF versus the lower MF during an equi-
hypocaloric diet is thought to delay gastric emptying and thus produce increased 
feelings of satiety (27). 
3. There will be a significant difference in total ghrelin concentrations preprandially 
and postprandially in response to the test meal between the two test conditions; 
“gorging” and “nibbling”.  
Rationale: According to Solomon et al., there is a larger preprandial surge in 
ghrelin response with larger, less frequent meals (two meals per day) compared to 
smaller more frequent meals (12 meals per day) (32). Reduced MF is thought to 
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play a role in disrupting metabolic balance by decreasing fat utilization and 
increasing fat storage (32). Furthermore, habitually reduced MF in obese subjects 
has been shown to have an effect on ghrelin concentrations. This eating pattern is 
associated with a negatively correlated relationship to body weight and percent 
body fat (31). 
Scope of the Study 
This study utilized an experimental randomized cross-over design. Testing 
occured under controlled medical supervision on location at Southwest Endocrinology 
Associates (SWENDO) as well as the University of New Mexico (UNM) Exercise 
Physiology Laboratory, both located in Albuquerque, NM. Medical and research staff on 
site include: physicians, nurses, exercise physiologists, dietitians, and trained research 
staff. Community-dwelling participants returned weekly to the clinic for follow-ups with 
the research team, attend education classes, and undergo measurements.  
An apriori power analysis using G*Power Version 3.1.0 (Franz Faul, Universitat 
Kiel, Germany) indicated that a sample size of four to ten was needed to determine 
significance; 15 subjects were recruited. The study design was a two arm, two-week 
randomized cross-over design with a two-week washout (six-weeks total) where non-
diabetic obese subjects (BMI ≥ 30 kg/m2) were randomly assigned to an equi-hypocaloric 
diet of either the “gorging” meal pattern of two meals per day or the “nibbling” meal 
pattern of three meals + three snacks per day as recommended by Nutrisystem®.  In 
accordance with SWENDO guidelines, dietary measures were standardized to restrict the 
dietary intake of all participants to 1200-1500 calories/day with a protein content of  
approximately 75g/day of protein depending upon body mass.  
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 Subjects were given an identical test meal (~400 kcals) at baseline and prior to 
both conditions. Venous blood was sampled and total ghrelin, insulin, and glucose 
concentrations were analyzed. Subjects answered questions of hunger and satiety using a 
visual analogue scale (VAS) at time 0, 30, 60, 90, and 120 minutes following 
consumption. Subjects consumed their assigned portion-controlled meal pattern for two 
consecutive weeks. Following a two-week washout period of four eating occasions per 
day, they consumed the alternate MF pattern. Subjects returned for weekly measurements 
throughout the six-week period. Measurements included resting blood pressure, body 
weight, height, waist and hip circumferences, body composition (Tanita BC-418, 
bioelectrical impedance analyzer). They also attended weekly meetings at SWENDO and 
received necessary counseling.  Following each two-week period, lipid profiles, glucose, 
insulin, and RMR were measured under fasting conditions. 
Assumptions 
The following assumptions were made for this study: 
1. Subjects ingest meals and/or snacks as instructed and in accordance with 
treatment condition and record all intake with time of ingestion. 
2. Food provided to the subject is eaten solely by the subject and is eaten in its 
entirety. If the subject did not consume the entire portion, subjects weighed the 
amount remaining and reported it on the food log. 
3. Subject maintains her current physical activity regimen and documents all 
activity. 
4. Subject follows all pre-test and pre-experimental guidelines as directed. 
5. Subjects answer all questionnaires accurately and truthfully.  
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Limitations 
1. Due to the nature of the study, we cannot observe all subjects during every eating 
occasion. Participants were free-living and adherence was maintained through 
self-report. It is a limitation that we are assuming the subjects will consume the 
allocated foods according to our instructions and that they will report this 
accurately.  
2. Due to the nature of the study, we cannot observe all subjects as they write in 
their food logs. Accuracy and completeness of logs were not controlled in this 
free-living sample. We assume food logs are correct and were completed with 
detailed descriptions of food consumed and at what time of the day it was 
consumed. 
3. Due to current resources and costs, a small sample size of approximately 15 
women were recruited. 
4. BIA (eight-electrode single frequency) was used to assess changes in body 
composition. The BIA will be used as an estimate of weekly body composition 
changes, if any. Total body water may be affected during weight loss which may 
be a factor that can influence BIA estimates. 
5. Due to limited resources, the time course of measurements for insulin, glucose, 
lipids, and total ghrelin were measured at only five time intervals (0, 30, 60, 90, 
120 minutes). 
Significance of the Study 
This project is significant because it is the first to investigate the effects of meal 
frequency on biochemical markers of appetite (total ghrelin) and health (glucose, insulin 
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and lipid concentrations) as well as hunger/satiety ratings in obese subjects utilizing 
portion-controlled products. Based on the results of the current study, this study can help 
recognize the affects of consuming two meals per day or six meals per day on certain 
blood-markers of health and appetite measures. With respect to the study population, this 
study aids in the understanding of the role altering MF has for obesity treatment.  
 
 
 
Definition of Terms: 
Acylated Ghrelin: The metabolically active form of ghrelin that has an acyl group 
attached. Acylated ghrelin is an endogenous ligand for the growth hormone secretagogue 
receptor (GHS-R1a) and stimulates feeding and growth hormone release. 
Adipogenesis: is the process of cell differentiation by which preadipocytes become 
adipocytes. 
Equi-Hypocaloric Diets: the comparison of two diets that provide equal macronutrient 
compositions and provides less caloric energy than is expended daily. 
Free-Living Diet: diet consumed without restriction at the free-will of the individual. 
Hypocaloric Diet: a diet that provides less caloric energy than is expended daily by the 
individual. 
Isocaloric Diet: diet providing equal macronutrient compositions and caloric energy per 
day compared with another diet. 
Meal: For this study, a meal will be ≥ 200 calories. 
Preprandial: prior to consuming a meal. 
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Postprandial: after consuming a meal. 
Thermogenesis: the process of heat production in organisms. 
Snack: There are varied definitions in the literature, but for this study, a snack will be 
≥100 - ≤ 200 calories. 
Serum Total Ghrelin: the sum of acyl- and desacyl- ghrelin which together forms the 
circulating concentration of the 28 amino acid hunger-stimulating peptide hormone 
synthesized by gastric endocrine cells. Ghrelin is the only circulating hormone that 
stimulates senses of hunger.  
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CHAPTER II 
 
This chapter represents a review manuscript entitled “Potential role of meal 
frequency as a strategy for weight loss and health in overweight or obese adults” that is 
currently in review for publication in the journal, Nutrition. The manuscript is authored 
by Michelle Kulovitz, Len Kravitz, Christine Mermier, Ann Gibson, Carole Conn, 
Deborah Kolkmeyer, and Chad Kerksick. This manuscript follows the formatting and 
style guidelines of the journal. References cited are provided at the end of the manuscript. 
The referred table is following the cited references, which is the formatting guideline for 
the submitted journal, Nutrition. 
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Abstract  
Improved dietary strategies for weight loss are necessary to decrease metabolic disease 
risk in overweight or obese adults. Varying meal frequency, i.e., increasing or decreasing 
eating occasions beyond the traditional three meal per day pattern, has been thought to 
have an influence on body weight regulation, hunger control, and blood markers of 
health. It is common practice for weight management clinicians to recommend increasing 
meal frequency as a strategy for weight management and to improve metabolic 
parameters. However, limited research exists investigating the impact of meal frequency 
during controlled hypocaloric diet interventions. Furthermore, meal frequency literature 
often speculates efficacy of meal frequency treatments based on research using normal 
weight, overweight/obese, and/or the combination where much diversity exists within 
these various populations. In this review we will discuss that normal weight and 
overweight/obese populations as well as free-living versus investigator-controlled 
research trials should be studied independently. There is uncertainty in the literature 
when interpreting optimal meal frequency for obesity treatment because of these 
comparisons.  Nevertheless, upon review of the scientific literature investigating 
overweight/obese adults during a hypocaloric dietary intervention, the relationship 
between meal frequency and body weight regulation, appetite, and health has not yet 
been determined. The objective of the present review is to survey the literature to assess 
if the alteration of meal frequency influences body weight regulation, hunger control, 
and/or blood markers of health in overweight or obese subjects undergoing a controlled 
hypocaloric diet to induce weight loss.  
Keywords: obesity, meal frequency, eating frequency, eating occasions, weight loss, 
hypocaloric diet, appetite 
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Introduction 
According to a recent release of Healthy People 2020, one primary public health 
concern in the United States is the prevalence of overweight and obese Americans (1). 
Currently, more than one-third of U.S. adults are obese with no indication that the 
prevalence is decreasing (2). It has been estimated that over 300,000 US adults (15.2% of 
all deaths) die each year due to obesity-related co-morbidities; of these factors, a poor 
diet and inadequate levels of physical activity hold great importance (3). 
Presently, there are numerous dietary strategies that are believed to play a role in 
combating overeating and obesity (defined as body mass index, BMI ≥ 30 kg/m2); 
however, the mechanisms are not well understood (4-6). For these reasons, evidence-
based weight loss interventions are considered crucial for decreasing the prevalence of 
overweight and obese Americans.  
Since the early 1960’s, the idea of implementing increased dietary structure in 
regard to meal frequency (MF) has been debated.  Currently weight management 
professionals recommend dietary weight loss plans that substitute the classical eating 
pattern (three large meals per day) with eating smaller meals more frequently throughout 
the day in order to spread out daily caloric intake (7, 8). Increased MF for weight 
management, body weight regulation, hunger control, and metabolic disease management 
is supported anecdotally, but this strategy lacks evidence in the associated scientific 
literature. Due to the potential impact of MF to manage hunger, satiety, regulation of 
appetite hormones, and lipemia, increasing MF has been hypothesized to impact energy 
intake and secondary to this, the favorable regulation of body weight (7, 9). Furthermore, 
it has been shown that weight loss maintainers tend to eat more frequently throughout the 
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day (3 meals and 2 snacks) than those who tend to regain weight lost, however the 
research is inconclusive during active weight loss (10). Thus it is the purpose of this 
review to investigate the role of MF as a dietary strategy for individuals undergoing 
active weight loss during controlled hypocaloric dietary interventions. 
Observational research has demonstrated mixed results in free-living adults versus 
controlled research trials when investigating the relationship between MF and body 
weight. Some researchers contend that higher MF is related to a healthy weight (8, 11, 
12). More specifically, those consuming a greater frequency of small meals throughout 
the day are more likely to have a normal BMI, healthy levels of certain markers of risk 
for diesease, (e.g. triglycerides, cholesterol, and glucose metabolism), and consequently, 
a reduced risk of developing or having a diagnosis of coronary heart disease (CHD) 
and/or other metabolic diseases such as obesity and type 2 diabetes (8, 11, 12). 
Conversely, others have reported that higher frequency of ad libitum eating may lead to 
increased weight gain and obesity because it presents increased opportunities to eat and 
overeat throughout the day (13-16).  
Furthermore, research investigating the role of MF in disease regulation has 
shown variable results when investigating glucose and insulin levels and postprandial 
lipid profiles.  Frequent meals have been proposed to reduce the occurrence of excess 
caloric consumption and provide better glucose control and reduced insulin secretion 
(17).  Benefits of increasing MF on glucose control have been shown in overweight/obese 
(18) and in individuals who have impaired glucose tolerance (19, 20); however, research 
with normal weight or those who are normoglycemic subjects are mixed.  
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Increasing MF in overweight or obese subjects has shown: reduced glycemic load 
(20), delayed nutrient absorption (18), improved glucose and insulin metabolism (19-22), 
and improved hunger control (18, 22). However in healthy normal weight individuals 
and/or persons without impaired glucose metabolism, no significant differences were 
found in postprandial glucose regulation (23), in reducing the concentrations of lipid 
and/or hormones (24), or in hunger feelings (25).  
Current Meal Patterns and Body Weight 
One of the most notable limitations in the literature examining eating patterns 
associated with MF is the predominance of observational, cross-sectional studies. In this 
regard, several studies have reported an inverse relationship between eating frequency 
and body weight, body composition, or BMI in both normal weight and obese adults (26-
28). According to a study investigating eating patterns and obesity prevalence in free-
living US adults, eating four or more times per day was associated with a lower risk of 
obesity when compared to eating three or less times per day (28). However, those who 
habitually skipped breakfast were 1.35 times more likely to be obese than those who 
always had breakfast (28). Research analyzing eating patterns of US adults showed that 
obese individuals eating ad libitum are more likely to skip breakfast, “gorge” during mid-
morning or lunch, and then “gorge” again for dinner with no snacks or meals in between 
(28).  Observational studies investigating eating patterns of weight-stable and weight-
gaining individuals showed that weight-gaining individuals eat an average of 1645 kJ/d 
more than weight-stable individuals; this difference is attributed to increased 
carbohydrate and fat consumption through larger portion sizes (29). These studies 
provide evidence for the need of more controlled feeding studies. Findings from Pearcey 
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and de Castro 2002 suggest that without holding total caloric intake constant the 
usefulness of MF and meal timing data can be limited (29).  
Current Limitations in the Literature 
Several limitations exist within the MF research to date. There is a lack of 
standardized terminology; eating occasions are described with multiple terms such as 
meal frequency, eating frequency, and feeding frequency. Furthermore, there are 
differences in definitions of caloric requirements for a meal or snack (11, 23, 30). 
Additionally, due to the differences in responses seen with the healthy normal-weight 
versus overweight/obese adults, comparisons should be made between similar 
populations rather than grouping them together.  Grouping different populations may 
produce differing responses to MF, lipid and glucose metabolism, hormonal appetite 
regulation, or sensations of hunger/satiety (21, 22, 24, 29). Differences also occur, in part, 
due to varied research methodologies; limited research exists using strict dietary and/or 
controlled methods. Although it is important to understand the behaviors of free-living 
adults, controlled trials should not be compared to free-living observational studies to 
investigate plausible strategies to be used by clinical professionals for weight 
management. Moreover, due to the common error seen with individuals underreporting 
caloric intake, there are other potential differences that can occur when drawing 
conclusions about optimal MF when using self-reported dietary intake versus portion-
controlled products (31). 
Therefore, the goal of this review is to clarify the impact of different MF on body 
composition and weight management, lipid and glucose metabolism, hunger and satiety, 
and hormonal appetite regulation in overweight/obese adults based on scientific evidence 
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from randomized controlled hypocaloric diet trials. Previous review papers investigating 
the impact of varied MF on these parameters have not studied the impact of MF with only 
overweight/obese adults undergoing a hypocaloric diet intervention to induce weight loss 
(14, 32-34).  Since outcome measures can vary between normal weight and 
overweight/obese subjects, the results of interventions with overweight/obese during a 
hypocaloric diet trial will be discussed in order to discern possible treatment mechanisms 
for obesity management. This paper will investigate randomized controlled research trials 
using reduced-calorie controlled dietary interventions that include altering MF. We also 
will assess whether there is evidence to suggest that increasing MF during a reduced-
calorie diet may be a treatment strategy for reducing obesity. Additionally, we will 
highlight areas in need of further research.  
Literature Search Criteria 
The scientific literature was reviewed and studies were incorporated in this review 
if they included healthy overweight or obese (BMI ≥ 25 kg/m2) adults (males and/or 
females ages 18-66 years) who were consuming a hypocaloric diet during a controlled 
feeding study. Keywords included in the search were a combination of “obese”, 
“hypocaloric”, “reduced calorie”, “meal”, “eating”, “frequency”, “occasion”, and 
“timing”. The following sources were used: MedLine, PubMed, Proquest, Cochrane 
Database, and Google Scholar. Studies published between 1970 and 2012 were included 
if they were written in the English language and incorporated a randomized study design 
with a hypocaloric dietary intervention in an overweight or obese population that 
investigated one or more of the following outcome measures: changes in body weight or 
composition; blood markers of health including glucose, insulin, or lipid concentrations; 
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hunger or satiety responses via appetite hormone measurements; or estimates of hunger 
sensation or satiety following a test meal.  A summary of studies yielded by the search 
criteria and distribution of terms provided is presented in Table 1. 
Body Composition 
A number of studies using both animal and human subjects have reported that MF 
can affect body weight and composition (26-28, 30).  Fabry and colleagues (1964) were 
among the first researchers to discover an inverse relationship associated with observed 
habitual MF and body weight in normal-weight humans (27). This research is thought to 
be largely responsible for the idea that meal timing may play a role in appetite regulation 
and body composition. Since that time, there has been much debate in the literature 
regarding the role of MF for the treatment of obesity as it relates to body weight and/or 
composition. For example, some recent cross-sectional studies have reported no 
relationship between MF and BMI or body fatness (9, 25, 35) while a 2007 study 
reported opposing results indicating a positive relationship between MF and obesity (30).  
Eight experimental studies investigating overweight/obese individuals during a 
hypocaloric weight loss intervention designed to induce body weight or composition 
changes met the search criteria. Limited evidence demonstrating a relationship between 
weight loss in the overweight/obese population and MF exists. Of these studies, the most 
recent was conducted by Bachman and Raynor in 2012 (9). This controlled trial 
randomized participants (age: 51±9.9 years, BMI: 35.5± 4.8 kg/m2, 57.8% female) into 
either a “gorging” three meals/day eating approach (n=25) or a “grazing” approach where 
they were instructed to eat at least 100 kcals every 2-3 hours and to distribute calories as 
they wished (n=26) (9). Assessments for weight loss and average hunger ratings were 
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done at 0, 3, and 6 months. No significant differences were found in energy intake or 
BMI between groups at any time point (9). It is important to note that subjects were told 
to maintain a non-individualized diet of either 1,200 kcals/day (body weight ≤ 200lbs) or 
1,500 kcals/day (body weight >200 lbs) for the 6-month study duration. Adherence was 
based on self-reported 3-day food records (9). 
Another study using a controlled experimental design was conducted by Cameron 
et al. in 2010 (25). They examined 16 obese (BMI 37.1±4.5 kg/m2) subjects during an 
eight-week equi-energetic hypocaloric diet. These subjects consumed either three meals + 
three snacks per day or three meals per day with no snacks. Loses of body weight, fat-
mass, and lean mass were similar between groups (25). Cameron and colleagues (25) did 
prescribe an individualized hypocaloric diet where a 700 kcal/day deficit was 
individualized to study participants.  
These findings are similar to a number of previously published studies (36-41), in 
which no significant differences were reported in body weight changes in 
overweight/obese subjects using three versus six eating occasions (36, 40, 41), four 
versus five eating occasions (37), or two versus three or five eating occasions (39). Only 
two of these studies used partial meal replacements and/or portioned products to alleviate 
some measurement error (37, 38). Other studies provided meal plans and relied on self-
reported intake for adherence. In this respect, Vander Wal and colleagues (38) used 
Kashi® products for breakfast, mid-morning snack, and lunch with a balanced meal for 
dinner, while Poston et al. (38) provided Slimfast® products to be eaten a minimum of 
two times/day. Although both used some portion controlled products, no significant 
differences were found in the amount of weight lost after eight (37) or 24 weeks (38). 
	  	  
26	  
Currently, there are many MF patterns that have been tested with respect to the 
number of meals/snacks administered as well as the duration of intervention. However, 
the research shows no significant findings were evident for changes in body composition 
with varied MF. At this time, it appears MF does not have a significant role in body 
composition changes or weight reduction during controlled feeding trials with 
overweight/obese adults. The lack of significant differences in weight loss or changes in 
body fat findings with varied MF may suggest that the differing patterns of MF and 
methods of measurement may or may not play a role in the results. The variable 
methodologies used in these studies makes it difficult to develop a conclusion with 
respect to the relationship between MF and body composition changes. Furthermore, 
based on the knowledge that underreporting of calories consumed is common in both 
obese and non-obese individuals, findings from studies using self-reported dietary intake 
must be interpreted with the caution due to the probability that underreporting has 
occurred (31).  
 
Markers of Health 
According to the Centers for Disease Control Summary of Health Statistics, 2010, 
34% of Americans 18 years and older are overweight and 28% are obese, while over 25% 
had been diagnosed with coronary heart disease (CHD).  Type 2 diabetes (T2DM), 
dyslipidemia, hypertension, and physical inactivity are some of the leading risk factors 
for developing CHD in the United States (42). There is a paucity of research on MF’s 
effect on metabolic markers of health inclusive of glucose and insulin metabolism as well 
as blood lipid concentrations during a hypocaloric diet for overweight/obese subjects. 
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There are several studies investigating the changes in postprandial insulin and glucose 
concentrations in normal weight (17, 23, 43, 44) and/or non-hypocaloric diet 
interventions (44, 45). After the review of studies meeting our search criteria, only seven 
studies were found that investigated one or more of the following: glucose 
concentrations, insulin responses, and/or blood lipid changes in overweight or obese 
populations.  
Insulin and Glucose Metabolism 
Mechanisms for improved glucose regulation in overweight/obese individuals or 
those with impaired glucose tolerance indicate that increased MF can decrease the 
postprandial surge of glucose and thus decrease the amount of insulin released in 
response (38). Furthermore, small sporadic meals are also thought to aid in T2DM 
management. They are thought to provide more stable blood sugar levels by increasing 
glucose uptake and disposal by the muscles as fuel as well as providing a possible 
suppression of free fatty acid (FFA) release from the adipose tissue (14, 21). Although 
there is very limited research on glucose and insulin responses and MF in 
overweight/obese subjects, a controlled study was conducted by Bertelsen et al. (19). 
T2DM patients (BMI 32.2±1.3 kg/m2) were studied to investigate postprandial glucose 
and insulin responses. Researchers investigated the differences between two isocaloric 
conditions in which two bolus feedings and six intermittent feedings were analyzed on 
separate occasions for differences in glucose and insulin responses (19).  They found that 
the two meal approach induced an 84% greater maximum amplitude in glucose 
concentrations as well as increased circulating FFA when compared to the six meal 
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approach (19). Their preliminary findings were indicative of poor metabolic control that 
can be ameliorated with higher MF in this population. 
However, research results investigating the changes in insulin and/or glucose 
responses to differing MF in healthy overweight/obese subjects are mixed; some found 
no significant differences (36, 38, 40), while others found significant differences between 
feeding patterns (18). Poston et al. (38) investigated if meal replacements with snacks 
would have an impact on blood glucose and insulin responses in obese men and women 
who were already “snackers” versus “non-snackers”. The researchers found no 
significant differences between those consuming three larger meals consisting of meal 
replacements and no snacks as compared to those consuming meal replacements plus 
snacks three times per day (38). The caloric prescription for this study required 
participants to maintain a daily diet of 1200 kcals for women and 1500 kcals for men.  It 
is important to note that the researchers relied on self-reported dietary intake by study 
participants, a condition in which underreporting of energy intake is known to occur (31). 
Similar findings were shown in a study by Forslund et al. 2008 (36), who studied 140 
obese adults eating on three versus six occasions per day during a one-year intervention. 
Individualized baseline caloric intake was assessed to adjust diets so that intake was 
reduced by approximately 30% to induce weight loss. Fasting glucose and insulin 
concentrations were assessed at baseline and one-year later with no significant 
differences being found between MF groups (36). Potential shortcomings of this study 
relates to the lack of postprandial glucose or insulin responses as well as the use of self-
reported food records and telephone interviews to determine compliance with caloric 
intake and allocated MF. Only fasting levels of glucose and insulin at baseline and 
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following the one-year intervention were used for assessment. Using similar methods and 
a 60-day intervention, Finkelstein and Fryer, (40) also reported no significant changes in 
fasting glucose concentrations from baseline to the follow-up in healthy young obese 
women.  
Heden et al. (18) recruited eight healthy obese women (BMI 34.5±1.3 kg/m2) for 
assignment into one of two isocaloric 12-hour treatment conditions of three eating 
occasions and six eating occasions. The changes in postprandial insulin concentrations 
were studied following both interventions. The insulin incremental area under the curve 
(AUC) was significantly higher during the three-meal condition when compared to the 
six-meal condition when subjects were followed for 12 hours. Insulin is thought to be 
indirectly related to the formation of fatty acids. Since insulin secretion upregulates 
enzymes known to be involved in cholesterol synthesis and enhance lipogenesis, 
increased insulin levels may promote the progression of CVD (11, 23).  
Blood Lipids 
Elevated levels of plasma triglycerides, LDL cholesterol, and total cholesterol 
combined with decreased concentrations of plasma HDL cholesterol are lipid profile 
markers associated with increased risk for coronary artery disease (46). Cross-sectional 
evaluations with the general population have found that both total cholesterol and LDL 
cholesterol are decreased with habitual increases in MF (47, 48). As with other areas, 
more research is needed to fully elucidate any relationship between MF and lipid profile 
changes, particularly in specialized in-need populations such as overweight/obese adults 
undergoing a reduced-calorie diet (11).  
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 Significant associations investigating MF and blood lipid concentrations were 
found in two studies meeting search criteria. In a randomized controlled trial (RCT) on 
MF by Forslund et al. (36) researchers found no significant differences between 
conditions for fasting levels of total cholesterol, LDL cholesterol, and triglycerides; the 
exception was HDL cholesterol. Using self-reported intake, those consuming three 
meals/day for one year were found to have significantly higher HDL cholesterol values 
than did those consuming three meals plus three snacks each day (36).  Additionally, 
Heden et al. (18) found a significantly lower AUC value for triglycerides during the three 
daily eating occasions as compared to the six-eating occasion condition in obese subjects. 
Researchers argue that one potential mechanism for these findings could be the greater 
postprandial insulin concentrations during the three-meal condition (see Postprandial 
Lipemia section) (18).  
Additionally, four other studies have also reported no significant differences in 
blood lipids due to varied MF in overweight or obese adults during a reduced-calorie diet. 
Vander Wal et al. (37) reported that an eight-week meal replacement program plus one 
late night snack did not significantly improve total cholesterol, LDL cholesterol, 
triglycerides, or HDL cholesterol values in obese adults. It appears that the intervention 
may not have been robust enough to see improvements in these parameters because only 
one extra eating occasion was added to the subject’s typical regimen. However, 
Finkelsein and Fryer, (40) Antoine et al. (41) and Poston et al. (38) reported similar 
findings. Collectively, no significant differences were identified relative to total 
cholesterol, LDL cholesterol, triglycerides, or HDL cholesterol following a 60-day RCT 
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with eight obese females, a two-week RCT with ten obese females, or a 24-week RCT 
with 100 obese adults, respectively.  
 Postprandial Lipemia  
Research using obese individuals following a hypocaloric intervention (18) and 
interventions designed to promote weight maintenance (23) have shown significant 
increases in postprandial insulin concentrations during a three-meal condition versus 
either six or 17 meals, respectively. Heden et al. (18) speculated that a possible 
mechanism for significantly lower triglyceride AUC for the three-meal condition is 
mediated by postprandial insulin responses. The increased insulin response is thought to 
lead to a decreased surge in triglycerides. Since insulin stimulates adipose tissue 
lipoprotein lipase activity this will function to hydrolyze triglycerides to non-esterified 
fatty acids and glycerol (18, 49). The non-esterified fatty acids are taken up by adipocytes 
and are then re-esterified into a triglyceride droplet to be stored (49). This lower 
triglyceride AUC is said to occur approximately one hour after the fall of the free fatty 
acids (49). Consequently, the increased insulin concentrations that occur because of an 
increase postprandial glucose surge during lower MF, may be increasing postprandial 
triglyceride clearance and its storage following meals (18).   
Overall, evidence showing changes in glucose and insulin responses and blood 
lipids in overweight/obese adults during a reduced calorie diet are limited. Some of the 
differences in study findings are thought to be because of differing MF, sample sizes, 
and/or study conditions (18). More controlled research designed to increase adherence 
and compliance to dietary interventions is needed. Currently, there is not enough 
evidence in the literature to support or refute the impact of MF during a hypocaloric diet 
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being beneficial for glucose and/or insulin control as well as blood lipid changes during a 
weight loss program. 
Appetite  
Hypocaloric diets often leave individuals feeling hungry.  This increases their risk 
of relapse and decreases compliance (38). However, a recent study has investigated an 
approach to reduce feelings of hunger by increasing MF and spreading out daily caloric 
intake (7). The effect of MF on hunger and satiety during a hypocaloric diet in 
overweight/obese individuals is less understood than with normal weight individuals.  
Hunger and Satiety Ratings 
There are papers which discuss MF and its effects on gastric sensations of 
“emptiness” or “fullness” prior to or following a meal (50), however only two studies 
were found using a controlled reduced-calorie diet of altered MF in overweight or obese 
subjects (9, 25). Eating more frequently has been thought to reduce hunger leading to a 
reduced overall energy intake (7, 9).  Bachman and Raynor (9) showed that participants 
in the “grazing” MF condition had a significant  reduction in hunger ratings, while those 
“gorging” had no significant changes in hunger throughout the duration of their study (9). 
These authors further suggest that consuming a reduced calorie diet to induce weight loss 
is better tolerated by obese patients when MF is increased (9).  Conversely, no significant 
differences were shown by Cameron and colleagues (25) for the desire to eat, hunger, 
fullness, or prospective food consumption. 
It has been suggested that the use of increased MF as a dietary strategy in free-
living adults is related to the amount of food consumed at subsequent meals. Using a 
small (N=7) sample size of obese men, Speechly et al. (51) investigated the effects of 
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eating 1/3 their daily energy needs (~1000 kcals) as either a single meal or as five equal 
portions on subsequent ad libitum food intake. Although there were no significant 
differences between hunger ratings, those consuming the single preload ate 27% more (or 
~358 kcals) during the ad libitum meal than those consuming the same meal in five 
portions (51). This study suggests that the increased MF can be a successful dietary 
strategy for reducing total daily caloric intake with some dietary portion and meal timing 
control. Future research merits investigation of this approach during a reduced calorie 
intervention for weight loss.  To date it is unknown if these same results can be a benefit 
when increasing MF in order to keep calories consumed less than expended.   
 Appetite Stimulating Hormones and Hypothalamic Control.  
The majority of the research investigating the hormonal responses of weight 
management and weight reduction interventions has studied the responses of two main 
hormones known to stimulate appetite: ghrelin and peptide YY (PYY) (8, 50). Ghrelin is 
a hormone produced primarily in the gastrointestinal tract where the majority of the 
hormone is secreted from the stomach to trigger the hypothalamus to sense feelings of 
hunger (50).  PYY is a gut hormone that belongs to the pancreatic polypeptide family. It 
is released in response to meals, and its reduction stimulates hunger cascades (52). Some 
researchers suggest that increasing MF may have a direct effect on gastric stretch, 
hormones, and emptying that contribute to hunger and satiety during weight loss (51). 
Solomon and colleagues (53), suggest that a larger preprandial surge in ghrelin occurs 
with larger less frequent meals which is influenced by the increased gastric stretch at 
meal times. This could cause hormonal influences that increase initiation of meals that 
can lead to more between-meal snacking behavior and a higher daily caloric intake (53, 
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54). Additionally, the postprandial release of ghrelin is somewhat mediated by the release 
of insulin; ghrelin and insulin have an inverse relationship in healthy normal weight 
adults (53, 55).  
Cameron et al. (25), conducted the only controlled feeding study found to 
investigate ghrelin and PYY in obese (BMI 37.1±4.5 kg/m2) individuals undergoing a 
controlled hypocaloric feeding study for eight weeks. They reported no significant 
differences in feelings of hunger, fullness, or ghrelin and PYY between groups 
consuming an equi-hypocaloric diet in either three or six meals per day (25). 
Although there is no unanimous agreement in the literature, it does appear that 
eating more frequently during a hypocaloric diet intervention can reduce hunger and 
increase satiety ratings compared to eating less frequently; however, the research using 
controlled feeding studies in overweight/obese adults is limited. Increased MF may lead 
to reduced consumption at subsequent meals and/or overall daily caloric intake (53). In 
conjunction with a hypocaloric diet plan, the impact of increasing MF and its ability to 
reduce hunger stimulating hormones and feelings of hunger offers an interesting 
preliminary mechanistic basis to warrant further implementation into practice. 
Regardless, more research is needed before we have the evidence to put this into practice. 
Conclusions 
While there is widespread anecdotal evidence, the amount of controlled research 
that has examined the impact of differing MF strategies is limited. Although more studies 
have been published recently, the availability of research in more specific populations of 
interest such as the overweight and obese is still lacking. Currently the literature lacks 
consistency in terms of the number of meals/snacks administered, as well as the duration 
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of interventions. Additional research is still needed to more fully understand the effects of 
MF on body weight and composition, markers of health, hunger and satiety ratings, and 
hormonal changes particularly in obese samples. Finally, most of the literature reviewed 
uses self-reported dietary intake for adherence to prescribed MF or caloric intake.  
Future Direction 
Interesting areas of exploration yet to be studied are changes in body composition, 
glucose, insulin, lipemia, and appetite measures in obese individuals utilizing pre-
packaged portion-controlled meal replacements for all food products consumed. This 
approach could be advantageous in order to minimize the underreporting error (a nearly 
ubiquitous problem with dietary interventions research), while also minimizing the 
logistical burden of eating more often. Although more evidence is becoming available, 
the literature surrounding the impact of meal frequency is still sparse. This area of 
research needs to be explored because of the associated findings that can be applied to 
clinical situations as well as the common desire to lose or better manage weight.  From a 
macro perspective this may be a small step toward attaining the Healthy People 2020 
goals of decreasing the current obesity prevalence and decreasing obesity-related co-
morbidities in the United States and across the globe. 	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CHAPTER III 
 
RESEARCH MANUSCRIPT 
 This chapter presents a research manuscript entitled “Meal frequency shows 
mixed results in blood-markers of health and appetite in obese women during an equi-
hypocaloric portion-controlled weight loss intervention”. This manuscript will be 
submitted to the Journal of the Academy of Nutrition and Dietetics. It is authored by 
Michelle Kulovitz, Jason Beam, James McCormick, Len Kravitz, Christine Mermier, 
Carole Conn, Ann Gibson, Robert Ferraro, and Chad Kerksick. The manuscript follows 
the formatting and style guidelines of the journal and provides the figures and tables 
following the cited references as requested by the target journal.  References are provided 
at the end of the chapter.  
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ABSTRACT  
Background: Increased meal frequency (MF) may be associated with improvements in 
blood-markers of health and appetite during weight loss; however this claim has not been 
investigated using portion-controlled products with obese women.  
Objective: To determine if consuming a portion-controlled equi-hypocaloric diet as a 
two meals per day (2 MF) or three meals plus three snacks per day sequence (6 MF) can 
be a successful strategy for obese women to improve weight loss, total ghrelin, glucose, 
insulin, lipid concentrations, and appetite regulation.  
Design: Eleven (N = 11) obese female subjects (BMI 39.1 ± 7.6 kg/m2) were randomized 
to either the 2 MF or 6 MF treatment condition for two weeks, completed a two-week 
washout, and alternated treatment conditions for the remaining two weeks.  
Results: Body mass was successfully lost (P < 0.05) under both feeding regimens (2 MF: 
2.8 ± 1.5 vs. 6 MF: 1.9 ± 1.5 kg). There were no significant differences found between 
conditions for fasting and AUC values of glucose, insulin, and total ghrelin. On average 
FFM decreased by 3.3 ± 2.6% following the 2 MF condition and an average increase of 
1.2 ± 1.7% in FFM following the 6 MF condition (P ≤ 0.05). Fasting HDL-C percent 
increased during the 2 MF condition was significantly greater than the 6 MF condition 
(1.3 ± 12.2% vs. 0.12 ± 10.3%) (P ≤ 0.05). In a similar fashion between conditions, there 
was a significant decrease in glucose AUC (2 MF:13,122  ± 1726 vs. 6 MF:12,296 ± 
1,870 mg/dL·120 min, P ≤ 0.05) and increased hunger ratings (2 MF: 1,894 ± 887 vs. 6 
MF: 3,131 ± 1,563 mm·120 min) independent of MF.  
Conclusions: Increased MF does not promote greater improvements in blood-markers of 
health, appetite control, or total-ghrelin levels during a portion-controlled reduced-calorie 
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diet intervention in obese women. While reduced MF may attenuate losses of HDL-C, 
increased MF may reduce FFM loss during weight loss. Based on our results, we cannot 
support an altered MF during an equi-hypocaloric diet as superior to a reduced-calorie 
diet alone. 
Keywords: ghrelin, obesity, hunger, appetite, reduced-calorie diet, eating frequency 
 
INTRODUCTION 
Obesity is a multi-factorial issue in clinical weight management. Changing eating 
behaviors by implementing increased dietary structure is becoming more commonly 
included in weight management strategies for patients undergoing supervised weight loss 
interventions. Some hypocaloric diets designed to induce body weight loss do, however, 
result in unfavorable metabolic changes that can lead to increased ratings of hunger and 
cravings, increased levels of key adipokines such as circulating ghrelin, as well as 
increased postprandial ghrelin concentrations following meals1.  
One fundamental principle that seems to be the most common component to 
clinically supervised hypocaloric dietary interventions is the idea of structured daily meal 
frequency (MF), where consuming meals at regular time intervals is thought to be 
associated with greater weight loss success2. Increased MF has been hypothesized to have 
an effect on energy intake and body weight regulation due to its potential role in resting 
metabolic rate (RMR), hunger and satiety, and appetite hormones (i.e. total ghrelin) 1, 3.  
Currently, there is limited research with obese (BMI ≥ 30 kg/m2) subjects 
demonstrating any impact of MF on metabolic blood-based markers of health including 
glucose and insulin responses, serum lipid concentrations, and levels of specific appetite 
hormones (i.e. serum total ghrelin). Abnormal levels of circulating low-density 
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lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), total 
cholesterol, triglycerides (TG), and insulin levels are acknowledged as factors that may 
increase cardiovascular disease (CVD) risk4. Presently, findings on the impact of altering 
MF on serum lipid, glucose, and insulin concentrations using obese 4-7 or normal weight 
adults 8-11 is inconclusive. Moreover, few studies have investigated the impact of MF and 
blood-based markers of health using obese subjects undergoing a clinically supervised 
weight loss trial 5, 6, 12. It has been noted that many different people, but in particular 
obese individuals, significantly underreport their energy intake. Furthermore obesity was 
found to be a significant predictor of underreporting energy intake 13, 14. Secondary to 
these known outcomes, it is surprising that most MF studies investigating changes in 
various metabolic markers of health have relied on self-reported dietary intake 4, 6, 8, 11. 
On the contrary, very few studies have provided portion-controlled meals and/or meal 
replacements to control for measurement and portion control error 5, 7, 9.  
Human appetite regulation in response to weight changes involves multiple 
complex biochemical regulatory pathways within the body that result in many factors that 
influence human hunger and satiety sensations15. According to a recent review, the 
evidence supporting the influence of MF on appetite regulation is inconclusive 16. It has 
been suggested that a “nibbling” or grazing pattern of eating (eating more frequently 
throughout the day) may exert various favorable metabolic benefits (i.e increased resting 
metabolic rate, and/or improved markers of health) when compared to “gorging” (eating 
≤ 2 meals per day) 16. However, consistency within the literature is lacking in regard to 
MF and the optimal number of meals and/or snacks per day for weight management.  
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Consistent reports in the literature indicate that consuming an equi-hypocaloric 
diet of differing MF during weight loss has no statistically significant impact on the 
amount of weight that is lost following 60 days to eight-weeks of active weight loss 12, 17-
19. However, some evidence exists to suggest that increased MF may improve both blood-
based markers of health and fuel utilization, indicators of appetite, as well as hunger 
ratings4. In consideration of these findings, it remains possible that altering MF may help 
with weight loss and weight maintenance in overweight or obese individuals 1, 4, 5, 19, 20.  
To date, no research study has investigated changes in blood-markers of health, 
hunger and appetite responses of obese women during a strict calorie- and portion-
controlled hypocaloric diet examining the impact of two meals per day versus six meals 
per day to induce weight loss. The use of portion-controlled products may assist in 
compliance with a reduced-calorie diet because they do not require the subject to weigh 
or measure food items. This may alleviate some of the underreporting error that is 
commonly associated with food recall accuracy by obese individuals.  Thus, the primary 
purpose of the present study was to determine the changes in total-ghrelin, blood glucose, 
insulin, lipid concentrations, and sensations of hunger due to an equi-hypocaloric diet 
intervention with varying meal frequency in obese women during a “gorging” (two meals 
per day sequence, 2 MF) versus “nibbling” (three meals and three snacks per day, 6 MF) 
sequence. We hypothesized that the extent of change in postprandial blood-markers of 
health would be more favorable and sensations of hunger would be less following the 
“nibbling” sequence.  
MATERIALS AND METHODS 
Subjects 
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Fifteen non-diabetic obese women aged 35-60 years with a BMI ≥ 30 kg/m2 were 
recruited for this study (Table 1). Eleven subjects completed the study. Two subjects 
were withdrawn due to non-compliance; one subject withdrew due to family issues, and 
the other withdrew due to time constraints. The Human Research Review Committee 
(HRRC) of the University of New Mexico approved this study prior to the 
commencement of testing. All subjects were tested at a local weight management clinic: 
Southwest Endocrinology Associates Weight Management Center located in 
Albuquerque, NM.  
The inclusion criteria for all study participants required that they were: non-
diabetic, currently following a sedentary to moderately-active lifestyle, weight stable or 
gaining (≤ 3kg over the last 6 months), eating ≤ four meals and/or snacks per day, able to 
travel to the clinic for weekly meetings, able to travel biweekly to the clinic in the 
morning for blood draws, and able to have a venous catheter placed for blood collection.  
Individuals were excluded if they were: using medications (i.e diuretics, some 
glucosamides, etc) or dietary supplements (i.e. ephedra, thermogenics, capsaicin, 
caffeine, or any herbal or botanical purported to increase weight loss) that could affect 
body composition, have a pacemaker, were a current a smoker or nicotine user, 
experienced a loss in body weight >3 kg over the last six months, or experienced any 
dramatic change in physical activity patterns within the six months prior to the onset of 
the study. Other exclusion criteria included being previously diagnosed or treated for: 
diabetes, abnormal thyroid conditions, liver or kidney diseases, gastrointestinal problems 
that could affect dietary adherence or absorption, cancer or other wasting disorders, were 
pregnant, lactating, or were planning to become pregnant during study duration. 
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Moreover, any participant who was unwilling to comply with any aspect of the study 
protocol (i.e. travel to the testing site weekly, attend group or individual intervention 
meetings, assessments, complete a daily detailed food diary, or properly store food 
provided for the study duration) was excluded. Lastly, any individual who presented with 
or reported an allergy to soy, peanut, latex, had a gluten intolerance or sensitivity or had 
an active eating disorder was excluded. 
Eligible subjects who were currently prescribed and/or taking anti-hypertensive or 
lipid-lowering medications were asked to maintain all medications as prescribed. All 
subjects were asked to maintain their usual physical activity levels, document all physical 
activity, and to refrain from drinking alcoholic during the study.   
Participants were required to sign an approved informed consent form prior to 
their participation. Subjects completed a preliminary screening, which included: health 
history, meal frequency, and physical activity questionnaires. Participants completing 
the preliminary screening who met all eligibility requirements, attended the orientation 
meeting, completed baseline assessments were randomized into one of two treatment 
conditions.  
Design  
This research study utilized a randomized, cross-over, repeated measures quasi-
experimental design which consisted of four testing sessions conducted at similar times in 
the morning. Additionally, participants were required to meet weekly at the clinic for 
measurements and behavioral education sessions. 
Compliance and Retention 
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A group orientation and familiarization meeting for all study participants was 
mandatory for inclusion in the study. Subjects were taught how to log food intake and 
time of food intake, how to log physical activity, and how to use their food scale. If a 
subject did not consume all the food provided they were asked to weigh the food left over 
and document it in their food log. Additionally, subjects received weekly reminders of  
the importance of adherence, accuracy, and truthfulness of dietary intake and physical 
activity reporting, regardless if they strayed from the prescribed meal plan or their normal 
physical activity pattern at any time point during the study. 
 
Meal frequency intervention 
Subjects were randomly assigned to an equi-hypocaloric diet of either the 2 MF 
meal pattern or the 6 MF meal pattern. The 2 MF pattern participants were instructed to 
consume allocated meals every 5-6 hours while awake; while the 6 MF pattern 
participants were instructed to consume allocated meals/snacks every 2-3 hours while 
awake. Meals provided to subjects were defined as an eating occasion with a caloric 
intake between 200 and 300 kcals, while a snack was defined as an eating occasion 
between 100 and 200 kcals. During the washout phase participants were instructed to 
consume the allocated meals and snack every 3-4 hours. Throughout all treatment 
conditions food products were identical as subjects received the identical assortment of 
pre-packaged food products for the study duration. Dietary measures were standardized 
ensuring the dietary intake of all participants was approximately 1200 calories/day with 
~75g/day of protein. Daily subject dietary macronutrients averaged 52% carbohydrates, 
27% protein, and 21% fat.  Subjects consumed their designated meal pattern eating only 
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Nutrisystem® meal products which were supplied to the subject. Participants also 
supplemented this diet with a limited selection of Nutrisystem® approved fresh fruits and 
vegetables in specific quantities. Fresh items added accounted for only  approximately 
187 kcals/day, 10% of daily caloric intake of the subjects’ daily total of ~1200 kcals per 
day. The subjects consumed identical food products throughout the study. Subjects were 
randomized into one of the two MF patterns for two weeks (Phase I). Following a two-
week period of three Nutrisystem® meals + one snack per day (Washout), the subjects 
consumed the alternate pattern for two weeks (Phase II).  
 
Protocol for experimental trial visits 
Participants reported to the clinic in the morning after a 12- hour overnight fast 
with water ad libitum and having completed a dietary and food recall log. Subjects 
voided their bladder and bowels prior to measurements. The measurements included: 
resting metabolic rate, body weight (BW), height, waist and hip circumferences, and 
body composition. 
Subsequently, they consumed a test meal (400 kcals, 49% carbohydrates, 25% 
protein, 26% fat) at baseline, following Phase I, prior to and following Phase II. This test 
meal was chosen because it was of similar macronutrient content as the daily 
macronutrient composition of the prescribed meal plan and it contained the average 
caloric intake of meals for both the 2 MF and 6 MF conditions (similar to the meals 
consumed during the washout condition). Following each two-week period, lipid profiles, 
glucose/insulin metabolism, and RMR were measured under fasting conditions. 
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 Participants also engaged in weekly group/individual meetings that utilized 
identical educational content and behavior modification strategies important for weight 
loss and weight maintenance. This also provided participants the opportunity to ask 
questions and discuss concerns.  
 
Experimental procedures 
Anthropometric measurements 
Anthropometric measurements taken by trained research personnel include: waist 
and hip circumferences, height, and weight. Barefoot standing height was measured to 
the nearest one cm using a standard wall stadiometer (SECA Model #2161814009). Body 
weight was measured to the nearest 0.1 kg using a calibrated body weight scale (UWE 
Model# UFM-L-300). Waist circumference was measured over light clothing to the 
nearest 0.5 cm superior to the suprailiac crest, and hip circumference was measured to the 
nearest 0.5 cm at the largest circumference of the hips and buttocks. For body 
composition estimation, subjects were asked to follow all recommended pre-test 
guidelines for bioelectrical impedance analysis per manufacturer instructions prior to 
each measurement. The Tanita-BC-418 eight-electrode bioelectrical impedance analysis 
device (Tanita Corporation, Arlington Heights, IL, USA) was used to assess average 
changes in body composition in relation to changes in percent body fat (%BF), fat-free 
mass (FFM), and fat-mass (FM). This device has been validated for use in adult 
populations (BMI: 16-41 kg/m2) for body composition analysis 21.  
Resting metabolic rate (RMR) 
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RMR was tested using the BodyGem ® (Microlife, Clearwater, FL) in accordance 
with manufacturer instructions. BodyGem® has been validated against a metabolic cart 
in healthy normal weight individuals and was found to be more accurate than using 
Harris-Benedict prediction equations for RMR 22. Participants were seated in a quiet 
room and had not participated in any strenuous exercise for at least 24-hours prior to 
measurement. RMR was measured prior to beginning and upon completing each two-
week MF condition (baseline, week two, week four, and week six).  
Blood sampling 
Venous blood samples were collected using a 22-gauge Teflon catheter inserted 
into an antecubital arm or dorsal hand vein of the participant. A baseline blood sample 
(~15 mL) was collected into sterilized vacutainer serum separator tubes. Following 
consumption of the test meal, a blood sample was collected every 30 minutes over a two-
hour period (0, 30, 60, 90, 120 minutes). The samples were first allowed to clot and then 
were centrifuged (3500 rpm) at 25°C for 15 minutes. All serum samples were then stored 
in separate tubes at -80°C until analysis to minimize freeze-thaw cycles of the samples. 
Identical procedures were followed at each time interval. The catheter was kept patent by 
flushing with 1.0-2.0 mL of saline after every blood draw. 
Processing of blood samples 
Serum samples were sent to a local private laboratory (Albuquerque, NM) for 
determination of glucose and lipid panels (total-cholesterol, LDL-C, HDL-C, TG). Serum 
total-ghrelin (includes both acyl and des-acyl ghrelin) samples were analyzed in duplicate 
in house using an enzyme immunoassay kit (EZGRT-89K; EMD Millipore, St. Charles, 
MO). Serum insulin concentrations were analyzed in duplicate in house using an ELISA 
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kit (EIA-2935; DRG International, Inc. Springfield, New Jersey, USA). ELISA 
procedures were performed using a Bio-Rad iMark microplate reader (168-1130EDU, 
Bio-Rad,) at a wavelength of 450 nm. Standard curves were produced using a 4-
parameter logistic equation and Microplate Manager software (version 6.0) from Bio-Rad 
(Hercules, CA). High and low controls were calculated for total-ghrelin which yielded an 
average coefficient of variation of 5.1% for the high control and 13.94% for the low 
control. Control values for each insulin plate yielded an average coefficient of variation 
of 12.8%.   
Visual analogue scales  
 The visual analogue scales (VAS) were 100 mm in length; the scale and questions 
have been validated for sensations reproducibility in test meal studies15. Subjective 
satiety and hunger were assessed via four VAS questions at the same time intervals when 
blood was collected and analyzed (0, 30, 60, 90, 120 minutes following test meal 
consumption). Subjective measures assessed by the VAS included: hunger or feelings of 
"emptiness" (VAS1), satiety (VAS2), "fullness" (VAS3), and the "urge to eat right 
now"(VAS4).  
Statistics  
An apriori power analysis was performed to determine the number of subjects 
that would be needed to detect significant differences. A sample size of 10 was 
determined by a power estimation via G*Power Version 3.1.0 (Franz Faul, Universitat 
Kiel, Germany) utilizing statistical methods of ANOVA with repeated measures 
including within-subjects interactions.   
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All data are presented as means ± SD, and the data was analyzed using SPSS 
(version 19.0, Chicago, IL). Postprandial blood measurements following the test meal 
conditions were compared using the area under the curve (AUC), techniques as 
calculated in Prism (GraphPad Software, La Jolla, CA) using the trapezoidal method 23. 
Data for anthropometrics, RMR, as well as fasting and AUC measures for blood markers 
were analyzed using a one-way (four conditions) repeated measures ANOVA to identify 
significant within-subjects main effects. Pairwise comparisons using paired-samples t-
tests were conducted for any significant main effects with a Tukeys HSD post-hoc 
correction. Blood marker and VAS values during the two-hour trials were analyzed using 
a two-way (four conditions by five time points) repeated measures ANOVA to indentify 
if there any significant within-subjects main effects and intervention effects. Pairwise 
comparisons using paired samples t-tests were conducted for any significant main effects 
with a Tukeys HSD post-hoc correction. In order to observe changes between the 2 MF 
and 6 MF conditions, percent change data was calculated based on changes occurring due 
the two-week treatment condition. A value of P ≤ 0.05 was set to determine statistical 
significance. 
 
RESULTS 
Anthropometric and metabolic measurements  
Average subject characteristics and anthropometircs at baseline and at the six-
week follow up visit are shown in Table 1. There was a significant main effect for BW, 
BMI, waist and hip circumferences, FM, FFM, and percent body fat (%BF), observed 
after the six week intervention (P ≤ 0.05) (Table 1). Pairwise comparisons indicated that 
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BW, BMI, waist and hip circumferences, FM, FFM, %BF, were significantly lower after 
the 2 MF, washout, and 6 MF when compared to baseline (Table 2). On average there 
was a decrease of 3.3 ± 2.6% in FFM following the 2 MF condition, and an average 
increase of 1.2 ± 1.7% in FFM following the 6 MF condition (P ≤ 0.05) (Figure 1). In 
addition, FFM was found to be significantly higher (P ≤ 0.05) after the 6 MF condition 
(51.1 ± 8.7 kg) when compared to the washout (50.6 ± 8.9 kg). There was no significant 
main effect for condition or time for RMR from baseline to all other measured time 
points (P > 0.05). 
<<<Insert Table 1 about here>>> 
<<<Insert Figure 1 about here>>> 
Serum insulin and glucose  
Although, fasting concentrations of glucose and insulin decreased from baseline 
to the six-week follow-up, these differences were not significant. No significant main 
main effects of time were found  between fasting concentrations of glucose, insulin, or 
insulin AUC. Glucose AUC showed a significant decrease (P = 0.006) from baseline to 
the six-week follow up (Table 3). Additionally, as expected, there was a statistically 
significant main effect of time for glucose AUC between conditions (P = 0.009). Pairwise 
comparisons indicated that glucose concentrations at 60 post test meal were significantly 
(P = 0.022) lower at the six-week follow-up than at baseline (Figure 2). 
<<<Insert Figure 2 about here>>> 
Serum lipid panel 
No significant main effects of time were reported for fasting triglycerides, total 
cholesterol, or LDL-C between conditions; fasting HDL-C levels, however, were found 
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to be different across conditions (P ≤ 0.05). Pairwise comparisons indicated that there 
were significant differences between baseline and all other time points measured for 
HDL-C (P ≤ 0.05). In addition, percent changes in HDL-C were found to be significantly 
greater (P ≤ 0.05) during the 2 MF condition (1.3 ± 12.2%) when compared to the 6 MF 
(0.12 ± 10.3%). 
Serum total-ghrelin responses 
Fasting total-ghrelin values were found to be higher following the 6 MF condition 
compared to the 2 MF condition; however this change was not statistically significant 
(Figure 3).  Although the results were not significant, fasting baseline levels of total-
ghrelin at all other measured time points were increased (P > 0.05). Additionally, there 
were no significant main effects for fasting total-ghrelin and total-ghrelin AUC between 
conditions or at the six-week follow up.  
<<<Insert Figure 3 about here>>> 
Appetite Measures 
Changes in subjective hunger (VAS1), satiety (VAS2), fullness (VAS3), and the 
urge to eat (VAS4) showed significant increases when compared to baseline and 
following consumption of the test meal values independent of condition (P ≤ 0.05). 
However, there was a significant main effect for VAS1 AUC (P = 0.042) between 
conditions. Pairwise comparisons indicated that VAS1 AUC was significantly higher (P ≤ 
0.05) during the 2 MF, washout, 6 MF, and at the six-week follow-up conditions when 
compared to baseline.  
 
DISCUSSION 
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The aim of the present study was to determine the effects of a portion-controlled 
equi-hypocaloric diet of 2 MF and 6 MF on total-ghrelin, glucose, insulin, and lipid 
concentrations. Additionally, we investigated changes in sensations of hunger and satiety 
in obese women.  
The primary finding of this study was that a 2 MF sequence may result in a 
greater percent elevation in HDL-C concentrations when compared to the 6 MF 
sequence. Alternatively, FFM changes were limited under 6 MF when compared the 2 
MF sequence. In addition, fasting total-ghrelin, insulin, glucose, total-cholesterol, LDL-
C, and triglyceride concentrations did not differ significantly between two-weeks of 
consuming two MF conditions.  
A similar percentage of body weight was lost following the 2 MF (2.7 ± 1.4%) 
and 6 MF (2.0 ± 1.5%) conditions. Subjects had an average percent body weight loss of 
6.6 ± 1.6% (6.2 ± 1.9 kg) following the six-week trial. MF did impact the amount of FFM 
lost, but not the amount of FM lost between trials. There was a significant difference in 
FFM changes between the 2 MF and 6 MF treatment conditions whereby subjects 
experienced a 3.3 ± 2.6% average decrease following the 2 MF condition and a 1.2 ± 
1.7% average increase following the 6 MF condition (P ≤ 0.05) (Figure 1). Although 
urinary nitrogen was not measured during this study, a possible explanation is that 
subjects had greater nitrogen losses during the 2 MF condition versus the 6 MF condition. 
Even though dietary protein intake was held constant between trials, there have been 
reports that reduced MF can promote greater protein breakdown and perhaps greater 
amounts of weight lost as FFM due to the increased lengths of time between feedings18, 
24. During the 2 MF condition, subjects would typically go without eating for five to six 
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hours between main meals and 15-18 hours between their evening meal and the first meal 
of the following day. Additionally, the consumption of dietary protein throughout the day 
at six eating occasions versus two eating occasions may have a sparing effect on FFM in 
non-dieting scenarios as well as during weight loss; however, this should be confirmed 
with additional controlled research25, 26. 
In conjunction with the present findings, other studies have reported favorable 
changes in cholesterol components that mirror decreases in body mass27, 28, a change 
which may reduce the risk of CVD4, 29. When exercise is held constant, weight loss is 
associated with a reduction in HDL-C which may negatively impact the known beneficial 
properties of HDL-C with respect to atherosclerotic progression27. Results of the present 
study indicate that obese women consuming the 2 MF condition may be able to preserve 
greater HDL-C concentrations during weight loss as compared to consuming the same 
food and caloric intake in the 6 MF condition (Table 3). In accordance with previous 
findings in healthy normal weight females30, current results indicate that consuming a 2 
MF sequence results in a significantly greater percent change in HDL-C (P ≤ 0.05) when 
compared to the change seen during the 6 MF sequence (1.3 ± 12.2% vs 0.12 ± 10.3%, 
respectively).  Previous evidence also indicates that obese subjects consuming a 
hypocaloric diet with reduced meal frequency (three meals per day) may significantly 
decrease triglyceride concentrations when compared to six meals5; similar changes were 
also reported for total-cholesterol, insulin, and glucose concentrations in lean normal-
weight healthy men9, 31 and normal-weight men and women10 without calorie restriction.  
Findings from the present study do not support these outcomes. Non-significant 
reductions from baseline were seen for triglyceride, insulin, and glucose concentrations 
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with both feeding regimens (Table 3); no significant differences were revealed between 
the two feeding frequencies. Our findings may suggest that when a dietary intervention is 
carried beyond a single dose response, as a part of a portion-controlled weight loss 
program, meal frequency may no longer operate as an intervening force, but more work is 
needed to further explore this suggestion.  
Non-significant decreases in fasting insulin (9.3%) and insulin AUC (7.7%) were 
found with 6 MF in comparison to 2 MF. These findings are consistent with previous 
research that also indicated no statistically significant differences occurred between MF 
conditions for insulin in healthy normal-weight men32,  healthy normal-weight women 30, 
and overweight men and women 6, 33. In examining these data, high variability in 
individual responses reduced the ability to detect significance, but this does not eliminate 
the possibility that our findings may wield some level of practical or clinical significance. 
For example, in a study investigating increased MF on glucose and insulin concentrations 
in subjects with Type II diabetes mellitus, there was a significantly greater amplitude in 
glucose concentrations following the two meal condition versus the six meal condition34. 
These results were similar to our findings; we observed reduced insulin concentrations as 
well as a 0.56% increase and a 3.3% decrease in glucose AUC following the 2 MF and 6 
MF conditions, respectively (Table 3). Although these results were not statistically 
significant between the 2 MF and 6 MF conditions, we did see an overall significant 
decrease (P ≤ 0.05) in glucose AUC from baseline to the six-week follow-up (Table 3) 
indicating that weight loss, independent of meal frequency may be enough to 
significantly reduce glucose concentrations postprandially.  
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As anticipated, appetite measures using AUC calculations for the four VAS 
questions resulted in significantly increased perceived hunger rating (VAS1) AUC from 
baseline to all other measure time points (P ≤ 0.05). This indicates subjects were more 
hungry due to the reduced calorie diet. Interestingly, there were no significant differences 
in hunger ratings between the 2 MF and the 6 MF conditions. These results were similar 
to previous findings within healthy normal-weight subjects where increasing MF from 
three to six meals per day significantly increased hunger35-37. These results may indicate 
that when caloric intake is held constant within a controlled feeding study using 
portioned products, obese subjects may rate hunger to be higher independent of MF. 
Studies have found that obese individuals have an increased likelihood of underreporting 
of energy intake, especially with snack items4, 35.  Since previous research investigating 
hunger ratings based on test-meal responses in obese subjects used self-reported energy 
intake for adherence, it may be possible findings showing increase satiety rating may be 
due to underreporting errors resulting in increased caloric consumption.36 Some literature 
has also shown that increased MF can have a negative effect in body weight regulation 
because it increases the opportunities to eat and subsequently lead to more underreporting 
of energy intake.10, 35	  If,	  in	  fact,	  the	  use of portion-controlled products in the present 
study increased compliance and decreased associated underreporting error; this may 
indicate that total daily caloric intake may be independent of MF for hunger control in 
clinical practice.  
Circulating ghrelin is known to increase hunger ratings and display an 
endogenous secretory rhymicity that can be related closely with meal patterns 38. Our 
results indicated that both total ghrelin fasting concentrations and total ghrelin AUC were  
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found to be similar to baseline at all measured time points. Similar to our findings, diet-
induced weight loss has been associated with a decrease in postprandial ghrelin 
suppression1. We hypothesized that total ghrelin AUC concentrations would be lower 
following the 6 MF when compared to the 2 MF; however, total ghrelin AUC following 
the 2 MF condition was found to be lower than the 6 MF condition. Furthermore, fasting 
total ghrelin concentrations and AUC were 18.5% and 22.5% higher, respectively, 
following the 6 MF condition compared to 9.8% and 3.2% higher, respectively, following 
the 2 MF condition; this pattern is similar to previous findings in obese adults39. Total 
fasting ghrelin concentrations were found to be significantly correlated to fasting ratings 
of hunger (VAS1) at baseline (r = 0.650, P = 0.03) and following the 2 MF condition (r = 
0.641, P = 0.034), but not following the 6 MF condition. Previous evidence exists that 
caloric restriction alone is known to increase ghrelin levels and to be correlated with 
associated hunger responses in obese men40.    
 Findings of the current study should be interpreted within the context of the study 
limitations. Four of the original fifteen women withdrew or were dropped from the study. 
This confounded the already high individual variability in our data and subsequently 
reduced our statistical power. It does suggest, however, that changes in these parameters 
are not acute, and may require an adaptation to MF patterns. Furthermore, our two-week 
dietary manipulation in treatment conditions may not have been robust enough to elicit 
changes in glucose, insulin, or total ghrelin concentrations to a degree that produced 
statistical significance.  
CONCLUSIONS 
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 This is the first study to investigate changes in blood-markers of health and 
appetite regulation using all portion-controlled products during a meal frequency 
intervention. According to the present results, increasing MF to eating six occasions per 
day did not promote greater improvements in blood-markers of health, appetite control, 
or total ghrelin levels during a portion-controlled strict reduced-calorie diet intervention 
in these obese women. Within the context of this study design, reducing MF to two eating 
occasions per day may attenuate losses in the beneficial function of HDL-C during 
weight loss when compared to eating on six occasions per day.  Conversely, consuming a 
reduced-calorie 2 MF diet may contribute to greater losses in FFM, while a 6 MF 
approach may aid in preservation of FFM. Current evidence does not support increased 
MF as a successful strategy to aid in reducing subjective hunger or appetite control when 
strict dietary measures are taken to reduce underreporting error in obese women. Future 
research is needed with longer intervention periods of two versus six meals per day using 
portion-controlled products.  
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Figure 1. Percent change in FFM between the two-meal frequency (2 MF) and six-meal 
frequency (6 MF). When subjects consumed the 2 MF pattern for two-weeks, their 
percent change in fat-free mass (FFM) produced a significantly greater decrease in FFM 
loss during the 2 MF condition compared to an increase during the 6 MF condition (P ≤ 
0.05). 
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Figure. 2 There was a significant main effect for time for glucose between baseline to the 
six-week follow-up (P = 0.009).  *Significantly decreased at time 60 versus baseline (P = 0.022)	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a)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  b)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  c)	  	  	  	  	  
	  
	  
	  
	  
	  
	  
Figure 3. a) glucose, b) insulin, and c) total-ghrelin; responses to all conditions. There 
were no significant differences in average fasting values or AUC between conditions; a)P 
= 0.197  b)P = 0.211  c) P = 0.059 
  Baseline 2MF Washout 6MF
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BMI: body mass index, FM: fat-mass, FFM: fat-free mass, WC: waist circumference, HC: 
hip circumference, WHR: waist-to-hip ratio, %BF: percent body fat, RMR: resting 
metabolic rate. 
N=11,*P ≤ 0.05 vs baseline 
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2 MF: 2 meal frequency pattern, 6 MF: 6 meal frequency pattern, Washout: 4 meal 
frequency pattern, FM: fat-mass, FFM: fat-free mass, RMR: resting metabolic rate  
*P < 0.05 vs. baseline, †P ≤ 0.05 vs. washout 
 
 
 
 
 
 
 
 
 
!!
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2 MF: 2 meal frequency pattern, 6 MF: 6 meal frequency pattern, Washout: 4 meal frequency pattern,  
VAS: visual analogue scale questions 
aN=11  
 bN=10, One subject was not included due to missing data  
cTo convert Triglyceride mg/dL to mmol/L, multiply mg/dL by  0.0113. 
!!
75!
dTo convert total- cholesterol, HDL-cholesterol, LDL-cholesterol l mg/dL to mmol/L, multiply mg/dL by 0.026.  
eTo convert insulin µIU/L to pmol/L multiply µIU/L by 6.0.  
fTo convert glucose mg/dL to mmol/L, multiply mg/dL by 0.0555. 
gTo convert total-ghrelin pg/ml to pmol/L, multiply mg/ml by 0.296.  
 
 
*P<.05 vs baseline 
†P ≤ .05 vs 2 MF
	  	  
76	  
CHAPTER IV 
 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
SUMMARY 
The review manuscript entitled “Potential role of meal frequency as a strategy for 
weight loss and health in overweight or obese adults” summarized the current literature 
as it relates to meal frequency during weight loss and its function in obesity treatment. 
Due to the common belief that increasing meal frequency may have an impact on body 
weight and other factors, its role in obesity management was in need of review ground in 
scientific evidence. The objective of this review was to highlight only original research 
using a reduced-calorie diet for weight loss in overweight or obese subjects utilizing 
varied meal frequencies as a strategy for improving one or more of the following: weight 
loss, metabolic markers of health (including fasting glucose, insulin, lipid 
concentrations), and/or appetite responses. It is believed this comprehensive review can 
help provide some clarity within the literature regarding meal frequency as a potential 
treatment therapy to aid in weight loss, improve metabolic markers of health, and help 
with appetite control in overweight or obese adults.  The findings of this research review 
discussed that normal weight versus overweight/obese populations as well as free-living 
versus calorie-controlled research trials should be studied independently. Currently, 
because of these mixed comparisons, there is uncertainty in the literature when 
interpreting optimal meal frequency for obesity treatment. This review focused on the 
discussion of scientific literature using overweight/obese adults during a hypocaloric 
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dietary intervention, the relationship between meal frequency and body weight 
regulation, appetite, and health.  
The research manuscript entitled “Meal frequency shows mixed results in blood-
markers of health and appetite in obese women during an equi-hypocaloric weight loss 
intervention” provides evidence that altered meal frequency of either 2 MF versus 6 MF 
does not significantly alter fasting or area under the curve values for: insulin, glucose, 
total-ghrelin, or subjective hunger or satiety ratings in obese women serving as their own 
controls. Some mixed beneficial results were found after using portion-controlled 
products to aid in improving dietary compliance and reducing underreporting error. 
While reduced MF may attenuate losses of HDL-C, increased MF may reduce loss of 
FFM during weight loss. Based on these results, no conclusions can be made to indicate 
that altering MF during an equi-hypocaloric diet exerts any additional impact beyond 
those of a reduced-calorie diet. 
 
CONCLUSIONS 
 This research adds significant findings to the scientific literature on meal 
frequency because it was the first of its kind to use portion-controlled products during a 
meal frequency trial for obese women. Three significant findings have been identified. 
First, increasing MF to six eating occasions per day does not promote greater 
improvements in blood-markers of health, appetite control, or total-ghrelin levels during 
a portion-controlled strict reduced-calorie diet intervention.  Secondly, within the context 
of this study design, reducing MF to two eating occasions per day may attenuate losses in 
the beneficial function of HDL-C during weight loss when compared to eating six 
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occasions per day.  Lastly, consuming a reduced-calorie diet as 2 MF may contribute to 
greater losses in FFM, while a 6 MF may aid in preservation of FFM.  
 Current evidence does not support that increased MF is a successful strategy to 
aid in reducing subjective hunger or appetite control when strict dietary measures are 
taken to reduce underreporting error in obese women. Future research is needed with 
longer intervention periods of two versus six meals per day using portion-controlled 
products. 
 
RECOMMENDATIONS 
 This research may have been improved if researchers had access to subjects’ 
medical charts for blood markers such as fasting lipid, glucose, and insulin concentrations 
prior to beginning the trial. It is possible that the large variability seen in many variables 
was inherent in the sample and was present even before the intervention. Within the 
constraints of the study design, it was not possible to obtain baseline measurements for 
subjects until all of the subjects had completed the trial. By analyzing the data as it was 
collected, we would have been able to observe individual variability from the start. 
Additionally, this information would have provided valuable information to the 
researchers ensuring the subjects’ self-reported medical history was accurate could have 
alerted us to individuals with high baseline variability.  
We have three recommendations for future studies. First, the impact of meal 
frequency using portion-controlled products during a reduced-calorie diet for a longer 
duration than two weeks for each pattern should be investigated. Due to the testimonials 
from subjects regarding the duration of consuming only the portion-controlled products, 
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it may be advantageous to split subjects into two groups (2 MF and 6 MF) for the entire 
six-week duration compared to a cross-over design. Secondly, an investigation of the 
impact of meal frequency on the observed blood-markers of health and appetite along 
with a moderate-intensity and/or high-intensity exercise regimen would enrich the 
literature. Limited research exists investigating appetite responses in obese women 
following moderate and/or high-intensity aerobic exercise. It would be advantageous to 
investigate the impact of a reduced-calorie diet for weight loss using portion-controlled 
products in obese women in conjunction with moderate and/or high-intensity exercise for 
changes in the observed blood-markers of health and appetite. (3) Third, examining body 
composition and metabolic changes in obese women following a resistance training 
and/or combination resistance + aerobic training program while undergoing a reduced-
calorie diet for weight loss using portion-controlled entrees would provide additional 
insight into the influence of exercise modality on the variables of interest.
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 APPENDIX A. 	  
 UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER 
HIPAA1 AUTHORIZATION TO USE AND DISCLOSE 
PROTECTED HEALTH INFORMATION FOR RESEARCH PURPOSES 
 
Title of Study: Impact of meal frequency on appetite and blood markers of health 
in obese women utilizing an equi-hypocaloric diet during a behavioral weight loss 
intervention 
 
Principal Investigators: Dr. Len Kravitz, Ph.D. & Dr. Carole Conn, Ph.D. RD, LD, 
FACSM 
UNMHSC Department: Heath, Exercise, and Sports Sciences; Individual, 
Family, and Community Education 
Mailing Address:  MSC 04-1610, Johnson Center, University of New 
Mexico,       Albuquerque, NM 87131 
 
Co-Investigators: Michelle Kulovitz, M.S., Jason Beam, M.S., Ailish White, M.S., 
Christine Mermier, Ph.D., Ann Gibson, Ph.D, Micah Zuhl, 
Ph.D., Roy Salgado, M.S., James Jeremy McCormick 
 
Sponsor:   N/A  
 
1. What is the purpose of this form?  You have been asked to take part in a research 
study.  The consent form for this study describes your participation, and that 
information still applies.  This extra form is required by the federal Health Insurance 
Portability and Accountability Act (HIPAA).  The purpose of this form is to get your 
permission (authorization) to use health information about you that is created by or 
used in connection with this research. 
 
2. What if I don’t want my personal health information (PHI) to be used in this 
research study?  You do not have to give this permission.  Your decision not to sign 
this form will not change your ability to get health care outside of this research study.  
However, if you do not sign, then you will not be allowed to participate in the study.   
 
3. What PHI am I allowing to be used for this research?  The information that may 
be used includes:  a) Blood glucose, insulin, and lipid concentrations 
b) Blood acylated-ghrelin concentrations 
c) Height, weight, resting blood pressure, and waist and hip circumferences 
d) Resting energy expenditure 
e) Subjective responses to visual analogue scale questions 
 
4. Where will researchers go to find my PHI?  We will ask you to fill out a 
questionnaire about your health and your current eating patters. We may ask to see 
your personal information in records at hospitals, clinics or doctor’s offices where you 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 HIPAA is the Health Insurance Portability and Accountability Act of 1996, a federal law related 
to privacy of health information. 
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may have received care in the past, including but not limited to facilities in the UNM 
health care system.    
 
5. Where will researchers go to find my PHI?  We may ask to see your personal 
information in records at hospitals, clinics or doctor’s offices where you may have 
received care in the past, including but not limited to facilities in the UNM health care 
system.    
 
6. Who will be allowed to use my information for this research and why?  The 
researchers named above and their staff will be allowed to see and use your health 
information for this research study.  It may be used to check on your progress during 
the study, or analyze it along with information from other study participants.  
Sometimes research information is shared with collaborators or other institutions.  
Your records may also be reviewed by representatives of the research sponsor or 
funding agency, the Food and Drug Administration (FDA) to check for quality, safety 
or effectiveness, or the Human Research Review Committee (HRRC) for the 
purposes of oversight and subject safety and compliance with human research 
regulations.   
 
7. Will my information be used in any other way?  Your information used under this 
permission may be subject to re-disclosure outside of the research study and be no 
longer protected under certain circumstances such as required reporting of abuse or 
neglect, required reporting for law enforcement purposes, and for health oversight 
activities and public health purposes. 
 
8. What if I change my mind after I give this permission?  You can change your 
mind and withdraw this permission at any time by sending a written notice to the 
Principal Investigator at the mailing address listed at the top of this form to inform the 
researcher of your decision.  If you withdraw this permission, the researcher may 
only use and share your information that has already been collected for this study.  
No additional health information about you will be collected by or given to the 
researcher for the purposes of this study. 
 
9. What are the privacy protections for my PHI used in this research study?  
HIPAA regulations apply to personal health information in the records of health care 
providers and other groups that share such information.  There are some differences 
in how these regulations apply to research, as opposed to regular health care.  One 
difference is that you may not be able to look at your own records that relate to this 
research study.  These records may include your medical record, which you may not 
be able to look at until the study is over.  The HIPAA privacy protections may no 
longer apply once your PHI has been shared with others who may be involved in this 
research. 
 
10. How long does this permission allow my PHI to be used?  If you decide to be in 
this research study, your permission to access and use your health information in 
this study may not expire, unless you revoke or cancel it.  Otherwise, we will use 
your information as long as it is needed for the duration of the study. 
 
 
I am the research participant or the personal representative authorized to act on behalf 
of the participant.  By signing this form, I am giving permission for my personal health 
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information to be used in research as described above.  I will be given a copy of this 
authorization form after I have signed it. 
 
 
 
 
______________________   __________________________________  ______ 
Name of Research Subject   Signature of Subject/Legal Representative    Date 
 
 
___________________________________________________ 
Describe authority of legal representative  
 
 
_______________________________   __________________   __________ 
Name of Person Obtaining Authorization      Signature           Date 	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APPENDIX B. 
The University of New Mexico Health Sciences Center 
Consent to Participate in Research 
Impact of meal frequency on appetite and blood markers of health in obese women 
utilizing an equi-hypocaloric diet during a behavioral weight loss intervention 
3/20/2013 
Introduction 
You are being asked to participate in a research study that is being done by Dr. Len 
Kravitz and Dr. Carole Conn who are the Principal Investigators as well as Michelle 
Kulovitz, M.S., and their associates from the Department of Health, Exercise, and Sports 
Sciences at the University of New Mexico. This research is studying the effect of the 
number of eating occasions per day on weight loss, blood markers of health, and appetite 
control.  
Ingesting meals with the same amount of calories at different time periods throughout the 
day has been shown to have an effect on body weight regulation, metabolic disease 
management, and hunger. There is limited research with obese women undergoing a 
controlled weight loss trial with varied meal frequency. Our study will look at a reduced-
calorie diet using Nutrisystems ® portion-controlled meal entrees that will be consumed 
during both two occasions per day and six occasions per day for two weeks each. Our 
research team is questioning whether that the number of eating occasions per day may 
have an effect on the amount of weight lost, blood glucose, insulin, lipids, and/or appetite 
measures, and perhaps on how hungry you feel after eating. 
You are being asked to participate in this study because you are a non-diabetic woman 
between the ages of 35-60, with a body mass index (BMI) ≥ 30, who on average 
consumes meals or snacks on four occasions throughout the day, is sedentary to 
moderately active, weight stable (≤ 3 kg or 6.5 pounds over the last 6 months), and does 
not have any diagnosed uncontrolled cardiovascular, pulmonary, or metabolic diseases. 
Approximately 20 people will take part in this study conducted by the University of New 
Mexico.   
This form will explain the research study, and will also explain the possible risks as well 
as the possible benefits to you. We encourage you to talk with your family and friends 
before you decide to take part in this research study. If you have any questions, please ask 
one of the study investigators.  
What will happen if I decide to participate?  
If you agree to participate, the following things will happen:  
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Overview 1. You	  will	  be	  asked	  to	  visit	  Southwest	  Endocrinology	  Associates	  (SWENDO)	  or	  the	  UNM	  Exercise	  Physiology	  Lab	  in	  the	  Johnson	  Center	  on	  the	  University	  of	  New	  Mexico	  main	  campus	  eleven	  times	  over	  the	  course	  of	  6-­‐7	  weeks.	  2. During	  your	  first	  visit,	  you	  will	  attend	  a	  group	  orientation	  meeting	  where	  all	  aspects	  of	  the	  research	  study	  will	  be	  explained	  in	  detail	  and	  provide	  an	  opportunity	  for	  you	  to	  ask	  questions.	  	  3. Throughout	  the	  6-­‐7	  week	  trial	  you	  will	  be	  asked	  to	  visit	  either	  SWENDO	  or	  the	  UNM	  Exercise	  Physiology	  Lab	  on	  four	  separate	  occasions	  separated	  by	  2	  weeks	  for	  a	  test	  meal	  in	  the	  morning	  where	  you	  will	  have	  your	  blood	  drawn	  periodically.	  	  4. Additionally,	  throughout	  the	  6-­‐7	  week	  trial	  you	  will	  be	  asked	  to	  visit	  SWENDO	  weekly	  for	  group	  or	  individual	  meetings	  and	  weigh-­‐ins.	  	  
First Visit 1. During	  your	  first	  visit,	  you	  will	  sign	  this	  consent	  form,	  a	  HIPAA	  form,	  and	  fill	  out	  a	  health	  history	  and	  meal	  frequency	  questionnaire.	  Additionally,	  only	  your	  signed	  consent	  form	  will	  be	  added	  to	  your	  SWENDO	  medical	  chart.	  Additionally,	  your	  SWENDO	  physician	  will	  be	  aware	  of	  your	  study	  participation.	  2. After	  filling	  out	  paperwork,	  you	  will	  attend	  the	  participant	  orientation	  meeting	  where	  you	  will	  be	  shown	  and	  introduced	  to	  the	  responsibilities	  that	  will	  be	  asked	  of	  you	  throughout	  this	  study.	  This	  meeting	  will	  cover:	  	  
§ How to log food  
§ How to log daily physical activity 
§ Food scale use. If you do not consume all food provided or 
planned you will be asked to weigh left over food and document in 
food log. 
§ Importance of adherence, accuracy, and truthfulness with intake.  3. We	  will	  give	  you	  a	  food	  and	  physical	  activity	  log	  so	  that	  you	  can	  keep	  track	  of	  your	  food	  and	  physical	  activity	  three	  days	  before	  your	  second	  visit	  to	  SWENDO	  and	  throughout	  the	  study.	  	  	  4. We	  will	  explain	  to	  you	  how	  to	  complete	  this	  log,	  and	  we	  will	  also	  schedule	  the	  date	  and	  time	  for	  your	  second	  visit	  before	  you	  leave.	  5. We	  will	  also	  give	  you	  a	  sheet	  with	  pre-­‐test	  guidelines	  that	  you	  should	  follow	  before	  each	  test	  meal	  trial.	  
Second, Third, Fourth, and Fifth Two-Week Visits 1. Upon	  arrival	  to	  your	  second	  through	  fifth	  two-­‐week	  appointments	  to	  either	  SWENDO	  or	  the	  UNM	  Exercise	  Physiology	  Lab,	  you	  will	  void	  your	  bladder	  and	  bowel	  and	  change	  into	  lightweight	  clothing.	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2. We	  will	  measure	  your	  height,	  weight,	  and	  blood	  pressure	  	  3. Body	  composition	  will	  be	  estimated	  using	  a	  device	  where	  you	  stand	  barefoot	  on	  a	  platform	  while	  holding	  handles	  (bioelectrical	  impedance).	  This	  will	  take	  approximately	  two	  minutes.	  4. The	  calories	  you	  burn	  at	  rest	  (resting	  energy	  expenditure)	  will	  be	  measured	  using	  a	  hand-­‐held	  device	  that	  you	  breathe	  into.	  This	  will	  take	  a	  maximum	  of	  15	  minutes.	  This	  measurement	  is	  in	  addition	  to	  the	  typical	  testing	  done	  by	  the	  SWENDO	  program.	  5. We	  will	  prep	  either	  your	  right	  or	  left	  arm	  or	  hand	  for	  a	  needle	  stick.	  6. We	  will	  insert	  a	  flexible	  needle	  into	  your	  arm	  or	  hand	  that	  will	  remain	  throughout	  the	  rest	  of	  your	  visit.	  	  This	  will	  allow	  us	  to	  take	  your	  blood	  without	  having	  to	  stick	  you	  multiple	  times.	  7. We	  will	  draw	  16	  ml	  (~1	  Tbsp)	  of	  blood.	  	  We	  will	  then	  insert	  1	  ml	  (1/5	  tsp)	  of	  saline	  into	  the	  catheter	  to	  keep	  it	  from	  getting	  clotted	  by	  blood.	  8. We	  will	  set	  up	  your	  test	  meal	  and	  you	  will	  be	  asked	  to	  consume	  this	  test	  meal	  within	  15	  minutes.	  9. Thirty	  minutes	  after	  consumption	  of	  your	  test	  meal,	  we	  will	  draw	  1	  ml	  (1/5	  tsp)	  of	  blood	  and	  discard	  it.	  	  We	  will	  then	  draw	  16	  ml	  (~1	  Tbsp)	  of	  blood	  for	  later	  analysis	  of	  blood	  sugar	  and	  insulin	  concentrations,	  lipids,	  and	  acylated-­‐ghrelin	  (a	  hormone	  responsible	  for	  hunger).	  	  We	  will	  also	  ask	  you	  how	  you	  are	  feeling	  on	  a	  Visual	  Analogue	  Scale	  on	  your	  current	  hunger,	  satiety,	  and	  desire	  to	  eat.	  10. You	  will	  then	  sit	  and	  rest	  for	  2	  hours	  while	  we	  draw	  16	  ml	  (~1	  Tbsp)	  of	  blood	  every	  30	  minutes	  for	  120	  minutes.	  For	  each	  blood	  draw,	  we	  will	  draw	  1	  ml	  (1/5	  tsp)	  of	  blood	  and	  discard	  it.	  	  We	  will	  then	  draw	  16	  ml	  (~1	  Tbsp)	  of	  blood	  for	  later	  analysis	  of	  blood	  sugar	  and	  insulin	  concentrations.	  	  We	  will	  clear	  out	  the	  catheter	  with	  1	  ml	  (1/5	  tsp)	  saline	  to	  keep	  the	  catheter	  from	  clotting.	  We	  will	  also	  ask	  you	  how	  you	  are	  feeling	  on	  a	  Visual	  Analogue	  Scale	  on	  your	  current	  hunger,	  satiety,	  and	  desire	  to	  eat	  every	  30	  minutes.	  11. After	  the	  2	  hours,	  we	  will	  take	  the	  catheter	  out	  of	  your	  arm.	  12. We	  will	  schedule	  the	  date	  and	  time	  of	  your	  next	  two-­‐week	  visit	  and	  your	  weekly	  visit.	  13. We	  will	  ask	  you	  to	  consume	  all	  Nutrisystems	  ®	  food	  products	  that	  we	  will	  provide	  to	  you	  during	  your	  weekly	  clinic	  visits.	  	  14. You	  will	  be	  asked	  to	  follow	  the	  meal	  frequency	  pattern	  that	  you	  were	  randomly	  assigned	  to	  consume	  for	  two	  weeks.	  	  15. All	  food	  and	  beverages	  you	  consume	  will	  be	  asked	  to	  be	  recorded	  in	  your	  food	  diary	  along	  with	  the	  time	  you	  ate	  the	  food	  or	  beverage.	  16. You	  will	  repeat	  the	  above	  procedures	  when	  you	  come	  to	  SWENDO	  or	  the	  lab	  for	  your	  third,	  fourth,	  and	  fifth	  appointments	  scheduled	  every	  two	  weeks.	  17. These	  appointments	  will	  last	  four	  hours	  or	  less	  each.	  18. We	  will	  collect	  a	  total	  of	  85	  ml	  (5.7	  Tbsp)	  each	  visit	  for	  a	  total	  of	  340	  ml	  (23	  Tbsp)	  over	  the	  6-­‐week	  study.	  19. Results	  of	  all	  of	  your	  blood	  tests	  will	  be	  explained	  to	  you	  after	  the	  conclusion	  of	  the	  study.	  If	  during	  the	  study,	  any	  of	  your	  lab	  values	  (glucose,	  lipids,	  insulin,	  or	  acylated-­‐ghrelin)	  are	  outside	  the	  clinical	  range	  of	  normal,	  your	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SWENDO	  overseeing	  physician	  will	  be	  contacted	  for	  a	  follow-­‐up	  of	  any	  necessary	  blood	  parameters.	  	  
Weekly	  Meeting	  Visits	  20. You	  will	  be	  asked	  to	  attend	  weekly	  group	  or	  individual	  one-­‐on-­‐one	  meetings	  at	  SWENDO	  that	  will	  cover	  different	  topics	  that	  relate	  to	  healthy	  weight	  loss	  and	  behaviors	  that	  will	  help	  you	  during	  the	  study	  and	  after	  the	  study.	  21. During	  these	  weekly	  visits	  we	  will	  measure	  your	  height,	  weight,	  blood	  pressure,	  and	  re-­‐test	  your	  body	  composition	  analysis.	  	  22. These	  meetings	  will	  be	  1.5	  hours	  or	  less	  each.	  
How long will I be in this study? 
Participation in this study will take no more than a total of 20 hours over a period of 6-7 
weeks.  
What are the phases for the varied meal frequency protocol? 
You will be randomly assigned to a diet that is reduced calorie diet of approximately 
1200 calories per day to induce weight loss.  You will be randomized to either 2 large 
meals per day or 3 meals + 3 snacks per day. The 2 meal pattern will instruct you to 
consume provided meals every 5-6 hours (while you are awake), while the three meal 
pattern will instruct you to consume provided meals/snacks every 3-4 hours (while you 
are awake) daily. Food products will be identical and dietary measures will be 
standardized ensuring your dietary intake will be ~1200 calories/day with ~75g/day of 
protein. Your nutrients will average 52% carbohydrates, 27% protein, and 22% fat which 
has been shown to provide adequate calories and nutrients during weight loss and is 
currently consumed by thousands of Nutisystems ® customers.  You will consume your 
randomly selected meal pattern eating only Nutrisystems ® meal products provided to 
you and Nutrisystems ® directed grocery items for the entire study duration. You will 
consume your randomized meal frequency pattern for two weeks (Phase I), have a two-
week washout period of 3 meals + 1 snack per day (Washout), and then consume the 
alternate pattern for two weeks (Phase II).  All procedures for consumption and storage of 
food products will be covered during your first visit and/or orientation meeting. All 
Nutrisystems ® food products will be provided to you each week during your weekly 
clinic visits. 
What are the risks or side effects of being in this study?  
Changing	  Meal	  Pattern	  Risks	  
• Some	  people	  may	  feel	  inconvenienced	  to	  eat	  on	  a	  strict	  schedule.	  There	  is	  also	  a	  potential	  risk	  of	  discomfort/hunger	  as	  a	  result	  of	  eating	  a	  reduced	  calorie	  diet.	  You	  will	  be	  asked	  to	  consume	  all	  provided	  foods	  for	  the	  day	  during	  two	  meals	  and	  three	  meals	  and	  three	  snacks	  for	  two	  weeks	  each.	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There	  will	  be	  a	  two-­‐week	  washout	  period	  where	  you	  will	  be	  asked	  to	  consume	  the	  same	  diet	  with	  Nutrisystems	  ®	  food	  products	  as	  three	  meals	  and	  one	  snack	  per	  day.	  Additionally,	  some	  may	  find	  it	  inconvenient	  to	  record	  all	  food/beverages	  and	  exercise	  in	  a	  journal.	  
Blood Drawing Risks 
• Risks	  of	  blood	  drawing	  include	  fainting	  (<0.01%	  or	  <1	  out	  of	  10,000	  people),	  lightheadedness	  (<0.01%	  or	  <1	  out	  of	  10,000	  people),	  bruising	  at	  the	  site	  of	  needle	  puncture	  (~2%	  or	  ~2	  out	  of	  100	  people),	  and	  localized	  infection	  (<0.01%	  or	  <1	  out	  of	  10,000	  people).	  
Weight	  Loss	  Risks	  
• Although	  it	  is	  expected	  that	  you	  will	  lose	  some	  body	  weight,	  there	  is	  a	  possibility	  that	  you	  may	  not	  lose	  any	  weight	  during	  this	  study.	  
Loss	  of	  Privacy	  Risks	  
• There	  are	  risks	  of	  stress,	  emotional	  distress,	  inconvenience	  and	  possible	  loss	  of	  privacy	  and	  confidentiality	  associated	  with	  participating	  in	  a	  research	  study.	  	  
For more information about risks and side effects, ask the investigator.  
What are the benefits to being in this study?  
There are some direct benefits to you as well as societal and public health benefits of this 
research study. Since this study is investigating methods to induce healthy weight loss in 
obese women as it relates to body weight reduction, changes in body composition, 
changes in appetite hormones, lipids, and hunger ratings, it can provide benefits directly 
to you about changes in your body during a reduced calorie diet as well as potential 
benefits in hunger/satiety due to two eating occasions versus six eating occasions of the 
same daily caloric intake.  
Since this study will include a behavioral education program, the knowledge gained by 
the group and individual support classes, one-on-one couseling, and knowledge of 
portion control will be information that can help you in weight management.  
This study may elicit potential public health benefits to society, including advancement 
of knowledge for obesity therapies that include treatment strategies for obesity, related 
metabolic diseases, and appetite responses to a reduced calorie diet. Additionally, results 
of this resarch may be used in clinical practice by physicians, nurses, and registered 
dietitians to aid in weight management.  
What other choices do I have if I do not want to be in this study?  
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Your participation is voluntary, and if you decide to not be in the study then you will not 
be contacted again. Additional choices are available to you without participation in this 
research study. There are many choices for obesity treatment for women that include 
commercial or medically supervised diet and/or exercise programs that may or many not 
utilize physicians, registered dietitians, or registered nurses for consultations. You are 
encouraged to consult your primary care physician for advice on participation in this 
research study and/or to obtain further information on other weight management choices 
that may be right for you. 
How will my information be kept confidential?  
We will take measures to protect the security of all your personal information, but we 
cannot guarantee confidentiality of all study data.  
Information contained in your study records is used by study staff. The University of 
New Mexico Health Sciences Center Human Research Review Committee (HRRC) that 
oversees human subject research, and the Food and Drug Administration and/or other 
entities may be permitted to access your records. There may be times when we are 
required by law to share your information. However, your name will not be used in any 
published reports about this study.  
Your information will be stored in a locked cabinet in the UNM Exercise Physiology Lab 
and/or at SWENDO where only study personnel will have access to it.  In addition, you 
will be given a study number that will be used for data collection and analysis.  Your 
information will be destroyed after the completion of data analysis. Your name will not 
be used in any published reports about this study. Additionally, your name or other 
identifying information will not be given to Nutrisystems ® for solicitation of products or 
for any other reason. You will not be contacted by Nutrisystems ® at any point during the 
research study. 
What are the costs of taking part in this study? 
There are no costs to you for study related material. However, the cost for the regular 
SWENDO health care will be up to $180 for the 6-week duration. Additionally, there are 
costs of fresh produce, dairy, and lean protein from the grocery store, and your time. 
What will happen if I am injured or become sick because I took part in this study? 
If you are injured or become sick as a result of this study, UNMHSC will provide you 
with emergency treatment, at your cost.  
No commitment is made by the University of New Mexico Health Sciences Center 
(UNMHSC) or Southwest Endocrinology Associates (SWENDO) to provide free medical 
care or money for injuries to participants in this study.  
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In the event that you have an injury or illness that is caused by your participation in this 
study, reimbursement for all related costs of care will be sought from your insurer, 
managed care plan, or other benefits program. If you do not have insurance, you may be 
responsible for these costs. You will also be responsible for any associated co-payments 
or deductibles required by your insurance.  
It is important for you to tell the investigator immediately if you have been injured or 
become sick because of taking part in this study. If you have any questions about these 
issues, or believe that you have been treated carelessly in the study, please contact the 
Human Research Review Committee (HRRC) at the University of New Mexico Health 
Sciences Center, Albuquerque, New Mexico 87131, (505) 272-1129 for more 
information.  
Will I be paid for taking part in this study? 
You will not be paid for your time during this study. However the use of Nutrisystems ® 
portion-controlled entrees and products will be provided to you free of charge. You will 
receive free food products plus free shipping to be picked up at SWENDO for the 
duration of the study after your orientation session. 
How will I know if you learn something new that may change my mind about 
participating? 
You will be informed of any significant new findings that become available during the 
course of the study, such as changes in the risks or benefits resulting from participating in 
the research or new alternatives to participation that might change your mind about 
participating.  
Can I stop being in the study once I begin? 
Your participation in this study is completely voluntary. You have the right to choose not 
to participate or to withdraw your participation at any point in this study without affecting 
your future health care or other services to which you are entitled. The Nutrisystems ® 
food products will not be sent to you if you withdraw from the study.  
Whom can I call with questions or complaints about this study?  
If you have any questions, concerns or complaints at any time about the research study, 
Dr. Carole Conn, Dr. Len Kravitz or Ms. Michelle Kulovitz, or his/her associates will be 
glad to answer them at (505) 277-2658.  
If you need to contact someone after business hours or on weekends, please call (714)-
809-8528 and ask for Michelle Kulovitz.  
If you would like to speak with someone other than the research team, you may call the 
UNMHSC HRRC at (505) 272-1129.  
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Whom can I call with questions about my rights as a research participant? 
If you have questions regarding your rights as a research participant, you may call the 
UNMHSC HRRC at (505) 272-1129. The HRRC is a group of people from UNM and the 
community who provide independent oversight of safety and ethical issues related to 
research involving human participants. For more information, you may also access the 
HRRC website at http://hsc.unm.edu/som/research/hrrc/.  
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CONSENT 
You are making a decision whether to participate (or to have your child participate) in 
this study. Your signature below indicates that you/your child read the information 
provided (or the information was read to you/your child). By signing this consent form, 
you are not waiving any of your (your child's) legal rights as a research participant.  
I have had an opportunity to ask questions and all questions have been answered to my 
satisfaction. By signing this consent form, I agree to participate (or let my child 
participate) in this study. A copy of this consent form will be provided to you.  ____________________________	   ____________________________	   ___________	  	  Name	  of	  Adult	  Subject	  (print)	   Signature	  of	  Adult	  Subject	   Date	  	  	   	   	  
INVESTIGATOR SIGNATURE 
I have explained the research to the participant and answered all of his/her questions. I 
believe that he/she understands the information described in this consent form and freely 
consents to participate.  
_________________________________________________  
Name of Investigator/ Research Team Member (type or print)  _________________________________________________	   ___________________	  	   	  (Signature	  of	  Investigator/	  Research	  Team	  Member)	   Date	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APPENDIX D. 
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APPENDIX E. 
 
HEALTH HISTORY & MEAL FREQUENCY QUESTIONNAIRE 
HRPO # 13-097 	  Subject	  Number_____________________________	   	   Date___/___/___	   	  	  Phone	  (H	  or	  cell)___________________	  	  Age____	  	  	   Gender____	  	  	   Ethnicity_______	  	  	  	  	  	  
Email_____________________________________ 	  Emergency	  contact	  (name,	  phone	  #)______________________________________________	  	  
	  
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦	  
MEDICAL	  HISTORY	  	   	  
Physical 
injuries:_________________________________________________________________
_____ 
Limitations______________________________________________________________
_____________ 
Have you ever had any of the following cardiovascular problems?  Please check all that 
apply. 	   Heart	  attack/Myocardial	  Infarction____	   Heart	  surgery	   ____	   Valve	  problems	   _____	   	  	   Chest	  pain	  or	  pressure	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ____	   Swollen	  ankles	   ____	   Dizziness	   _____	  	   Arrhythmias/Palpitations	   ____	   Heart	  murmur	   ____	   Shortness	  of	  breath	   _____	   	   Congestive	  heart	  failure	   ____	  	   	   	  
Have you ever had any of the following?  Please check all that apply. 	   Hepatitis/HIV	   _____	   Depression	   _____	   Cancer	  (specifytype)	   ______	  
 Rheumatic fever ____ High blood pressure_____  Thyroid problems _____ 	   Kidney/liver	  disease	   _____	   Gastrointestinal	  Disorders	  _____	   Total	  cholesterol	  >200	  mg/dl	   _____	  	   Diabetes	  (specify	  type)	  _____	   Asthma_____	  	   HDL	  cholesterol	  <35	  mg/dl	   _____	  	   Emphysema	   _____	   Stroke_____	  	   LDL	  cholesterol	  >135	  mg/dl_____	  	  	  	  Pacemaker	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  _____	   	   Triglycerides>150	  mg/dl_____	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If you checked YES to one of the above please explain your current treatment: 
________________________________________________________________________
________________________________________________________________________ 
Do immediate blood relatives (biological parents & siblings only) have any of the 
conditions listed above?  If yes, list the problem, and family member age at diagnosis. 
________________________________________________________________________ 
Do you currently have any other medical conditions not listed?  
Details__________________________________________________________________
________________________________________________________________________ 
 
Indicate level of your overall health.  Excellent ____  Good ____   Fair ____  Poor_____ 
Are you taking any medications, vitamins or dietary supplements now?         Y      N 
If yes, what are 
they?__________________________________________________________________ 
Do you have allergies to any medications or supplements?  If yes, what are they?  
___________________________________________________________________ 
Are you allergic to latex? Y N 
Have you experienced a change in body weight ≥ 3 kg (6.6 lbs) within the last 6 months?    
Y       N 
If yes, elaborate.________________________________________ 
Have you ever been diagnosed with an eating disorder?   Y     N 
Are you pregnant or planning to become pregnant in the next 3 months?   Y     N  
What is your current menopausal status?  
 ☐Eumenorrheic            ☐Amenorrheic          ☐Premenopausal             ☐Menopausal  
 
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦ 
LIFESTYLE FACTORS 
Do you currently smoke?    Y    N                   Have you ever used tobacco/smoked?  Y  N     
If yes:  type _______________ 
How long?______   Quantity____/day   Years since quitting______________ 
How often do you drink the following? 
Caffeinated: coffee or tea  _________oz/wk  Soft drinks _________oz/wk 
   
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦ 
EXERCISE	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These questions will ask you about the time you spent being physically active in the last 7 
days. Please answer each question even if you do not consider yourself to be an active 
person. Please think about the activities you do at work, as part of your house and yard 
work, to get from place to place, and in your spare time for recreation, exercise or sport.  
 
In the last 7 days: 
Did you perform any exercise?        Y       N    
If NO, is this typical for you?   Y        N       Please 
explain_______________________________________ 
If YES, please answer the following: 
What did you do for exercise? ______________________________________________ 
How often? ______________days/ week       
How long did you typically perform your exercise? __________________ minutes/day 
Rate the intensity of your exercise:        ☐Light          ☐Moderate        ☐Vigorous 
Is the exercise this past week typical for you?   Y      N 
If NO, Explain: __________________________________________________________ 
Have you changed your exercise regimen dramatically within the last 6 months?       Y          
N 
If YES, How? ___________________________________________________________ 
 
 
♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦♦ 
MEAL FREQUENCY/FOOD INTAKE  
These questions will ask you about the amount of meals and snacks you had in the last 7 
days. Please answer each question to the best of your knowledge. If there was a 
disruption this past week to your typical eating pattern please explain. 
 
In the last 7 days: 
On average how many meals (≥200 calories) do you try to have in one day? __________ 
How many days/week do you eat this way?______________   
If variable, please explain__________________________________________________ 
On average how many snacks (100 to < 200 calories) do you have in one day? ________ 
How many days/week do you eat this way?______________   
If variable, please 
explain__________________________________________________________________ 
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On average how many times a day would you say you eat something ?_______________ 
Do you have any nut/soy allergies?   Y       N 
Do you have any food allergies?   Y      N       If YES, Please Explain________________ 
Are there any food items that you absolutely will/cannot not eat?    Y     N    If YES, 
Please Explain___________________________________________________________ 
Do you have freezer/refrigerator space to accommodate food to be provided to you? Y  N 
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APPENDIX F. 
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APPENDIX G. 
 
 
 
Weekly Data Collection Sheet- Participant Survey 
HRPO#13-097 
 
Participant #:________________ 
Date: ___________________ 
Trial #/Week #:_________________ 
 
1. Did you experience any discomfort this week with regards to the meal plan?    Y   /   N 
If so, Please 
explain___________________________________________________________ 
2. Overall, how would you rate your hunger this week?   
                    (not hungry at all)         1    2    3    4    5    6    7    8    9  10       (so hungry I 
couldn’t bare it) 
 
3.  How would you rate your adherence to the prescribed meal plan this week? 
         (didn’t follow it at all)     1    2    3    4    5    6    7    8    9  10       (I ate right on 
schedule every day) 
  
4.  Did you consume any foods that were not NutriSystems ® or NutriSystems ® 
prescribed grocery items?   Y   /   N 
If so, Please 
explain____________________________________________________________ 
 
5. Do you have any comments or concerns that you would like to express to the 
researchers?   Y  /   N 
If so, Please 
explain__________________________________________________________________ 
________________________________________________________________________
________________________________________________________________________	  
 
Thank you so much!!  
Your participation and adherence is vital to the advancement of research!!! 
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APPENDIX H. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 1. Individual subject results for percent change total ghrelin AUC. 
There were no significant differences for total-ghrelin AUC percent change. (P > 0.05). 
Dark grey bars = 2 MF, light shaded bars = 6 MF 
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APPENDIX I. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 2 Individual subject results for percent change for insulin AUC. 
There were no significant differences for Insulin AUC percent change. (P > 0.05) 
Dark grey bars = 2 MF, light shaded bars = 6 MF 
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